0001833197--12-312024Q1P0Y00http://fasb.org/us-gaap/2023#OtherAssetshttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent115389689114871782http://fasb.org/us-gaap/2023#OtherAssetshttp://fasb.org/us-gaap/2023#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrentfalse0001833197swim:RepurchaseProgramMember2024-03-300001833197swim:RepurchaseProgramMember2022-05-100001833197swim:RepurchaseProgramMemberus-gaap:CommonStockMember2024-01-012024-03-300001833197us-gaap:CommonStockMember2024-01-012024-03-300001833197us-gaap:CommonStockMember2023-01-012023-04-010001833197us-gaap:OverAllotmentOptionMember2021-04-272021-04-2700018331972021-04-132021-04-130001833197us-gaap:RetainedEarningsMember2024-03-300001833197us-gaap:AdditionalPaidInCapitalMember2024-03-300001833197us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-03-300001833197us-gaap:RetainedEarningsMember2023-12-310001833197us-gaap:AdditionalPaidInCapitalMember2023-12-310001833197us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-12-310001833197us-gaap:RetainedEarningsMember2023-04-010001833197us-gaap:AdditionalPaidInCapitalMember2023-04-010001833197us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-04-010001833197us-gaap:RetainedEarningsMember2022-12-310001833197us-gaap:AdditionalPaidInCapitalMember2022-12-310001833197us-gaap:AccumulatedOtherComprehensiveIncomeMember2022-12-310001833197us-gaap:CommonStockMember2024-03-300001833197us-gaap:CommonStockMember2023-12-310001833197us-gaap:CommonStockMember2023-04-010001833197us-gaap:CommonStockMember2022-12-310001833197us-gaap:EmployeeStockOptionMember2023-01-012023-12-310001833197us-gaap:EmployeeStockOptionMember2024-03-300001833197us-gaap:StockAppreciationRightsSARSMember2023-12-310001833197us-gaap:StockAppreciationRightsSARSMember2024-03-300001833197us-gaap:EmployeeStockOptionMember2023-12-310001833197us-gaap:StockAppreciationRightsSARSMember2023-01-012023-04-010001833197us-gaap:StockAppreciationRightsSARSMember2024-01-012024-03-300001833197us-gaap:EmployeeStockOptionMember2024-01-012024-03-3000018331972023-05-020001833197us-gaap:RestrictedStockUnitsRSUMember2024-03-300001833197us-gaap:RestrictedStockMember2024-03-300001833197us-gaap:PerformanceSharesMember2024-03-300001833197us-gaap:RestrictedStockUnitsRSUMember2023-12-310001833197us-gaap:RestrictedStockMember2023-12-310001833197us-gaap:RestrictedStockMember2024-01-012024-03-300001833197us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-300001833197swim:LinersMember2024-01-012024-03-300001833197swim:InGroundSwimmingPoolsMember2024-01-012024-03-300001833197swim:CoversMember2024-01-012024-03-300001833197swim:LinersMember2023-01-012023-04-010001833197swim:InGroundSwimmingPoolsMember2023-01-012023-04-010001833197swim:CoversMember2023-01-012023-04-010001833197us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-01-012024-03-300001833197us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-01-012023-04-010001833197us-gaap:RetainedEarningsMember2024-01-012024-03-300001833197us-gaap:RetainedEarningsMember2023-01-012023-04-010001833197us-gaap:MediumTermNotesMember2022-02-230001833197srt:MinimumMemberswim:NewRevolvingCreditFacilityMember2022-02-232022-02-230001833197srt:MaximumMemberswim:NewRevolvingCreditFacilityMember2022-02-232022-02-230001833197swim:NewRevolvingCreditFacilityMember2022-02-232022-02-230001833197swim:NewRevolvingCreditFacilityMember2024-03-300001833197us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2023-12-310001833197us-gaap:FairValueInputsLevel2Memberus-gaap:InterestRateSwapMember2024-03-300001833197us-gaap:UnpatentedTechnologyMember2024-03-300001833197us-gaap:OrderOrProductionBacklogMember2024-03-300001833197us-gaap:FranchiseRightsMember2024-03-300001833197us-gaap:EmploymentContractsMember2024-03-300001833197us-gaap:UnpatentedTechnologyMember2023-12-310001833197us-gaap:OrderOrProductionBacklogMember2023-12-310001833197us-gaap:FranchiseRightsMember2023-12-310001833197us-gaap:EmploymentContractsMember2023-12-310001833197us-gaap:CustomerRelationshipsMember2023-12-310001833197us-gaap:InterestRateSwapMember2023-03-100001833197us-gaap:InterestRateSwapMember2022-02-280001833197us-gaap:InterestRateSwapMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2023-03-100001833197us-gaap:InterestRateSwapMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-02-280001833197swim:NewRevolvingCreditFacilityMember2022-02-230001833197swim:SeniorSecuredTermLoanFacilityMember2024-03-300001833197swim:SeniorSecuredTermLoanFacilityMember2024-01-012024-03-300001833197us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MediumTermNotesMember2024-03-300001833197us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MediumTermNotesMember2024-03-300001833197us-gaap:FairValueInputsLevel2Memberus-gaap:EstimateOfFairValueFairValueDisclosureMemberus-gaap:MediumTermNotesMember2023-12-310001833197us-gaap:FairValueInputsLevel2Memberus-gaap:CarryingReportedAmountFairValueDisclosureMemberus-gaap:MediumTermNotesMember2023-12-310001833197us-gaap:MediumTermNotesMember2024-03-300001833197us-gaap:MediumTermNotesMember2023-12-310001833197srt:MinimumMemberswim:SeniorSecuredTermLoanFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-02-232022-02-230001833197srt:MinimumMemberswim:SeniorSecuredTermLoanFacilityMemberus-gaap:BaseRateMember2022-02-232022-02-230001833197srt:MaximumMemberswim:SeniorSecuredTermLoanFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-02-232022-02-230001833197srt:MaximumMemberswim:SeniorSecuredTermLoanFacilityMemberus-gaap:BaseRateMember2022-02-232022-02-230001833197swim:NewRevolvingCreditFacilityMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2022-02-232022-02-230001833197swim:NewRevolvingCreditFacilityMemberswim:EuroInterbankOfferedRateAndAustralianDollarRateMember2022-02-232022-02-230001833197swim:NewRevolvingCreditFacilityMemberswim:CanadianPrimeRateMember2022-02-232022-02-2300018331972023-04-0100018331972022-12-3100018331972023-01-012023-12-310001833197us-gaap:StockAppreciationRightsSARSMember2024-01-012024-03-300001833197us-gaap:RestrictedStockUnitsRSUMember2024-01-012024-03-300001833197us-gaap:RestrictedStockMember2024-01-012024-03-300001833197us-gaap:EmployeeStockOptionMember2024-01-012024-03-300001833197swim:PerformanceStockUnitsMember2024-01-012024-03-300001833197us-gaap:RestrictedStockUnitsRSUMember2023-01-012023-04-010001833197us-gaap:RestrictedStockMember2023-01-012023-04-010001833197us-gaap:EmployeeStockOptionMember2023-01-012023-04-010001833197us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-01-012024-03-300001833197us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-01-012023-04-010001833197us-gaap:CostOfSalesMember2023-01-012023-04-010001833197us-gaap:AdditionalPaidInCapitalMember2024-01-012024-03-300001833197us-gaap:AdditionalPaidInCapitalMember2023-01-012023-04-010001833197us-gaap:NonrelatedPartyMember2024-03-300001833197us-gaap:RelatedPartyMember2023-12-310001833197us-gaap:NonrelatedPartyMember2023-12-310001833197swim:BrightAiServicesMember2023-12-3100018331972021-04-122021-04-120001833197us-gaap:IPOMember2021-04-272021-04-270001833197swim:SeniorSecuredTermLoanFacilityMember2022-02-232022-02-230001833197swim:SeniorSecuredTermLoanFacilityMember2022-02-230001833197swim:IfPerformanceTargetLevelEarnedAt200Memberus-gaap:PerformanceSharesMember2024-01-012024-03-300001833197srt:MinimumMemberus-gaap:PerformanceSharesMember2024-01-012024-03-300001833197srt:MaximumMemberus-gaap:PerformanceSharesMember2024-01-012024-03-300001833197us-gaap:PerformanceSharesMember2024-01-012024-03-300001833197swim:RoundingMember2024-03-300001833197us-gaap:TrademarksAndTradeNamesMember2024-03-300001833197us-gaap:TechnologyBasedIntangibleAssetsMember2024-03-300001833197us-gaap:CustomerRelationshipsMember2024-03-300001833197swim:PoolDesignsMember2024-03-300001833197us-gaap:TrademarksAndTradeNamesMember2023-12-310001833197us-gaap:TechnologyBasedIntangibleAssetsMember2023-12-310001833197swim:PoolDesignsMember2023-12-3100018331972024-03-3000018331972023-12-3100018331972023-01-012023-04-0100018331972024-05-0300018331972024-01-012024-03-30xbrli:sharesiso4217:USDxbrli:pureiso4217:USDxbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 30, 2024

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from     to    

Commission file number: 001-40358

Latham Group, Inc.

(Exact name of registrant as specified in its charter)

Delaware

    

83-2797583

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer Identification No.)

787 Watervliet Shaker Road, Latham, NY

12110

(Address of principal executive offices)

(Zip Code)

(800) 833-3800

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common stock, par value $0.0001 per share

SWIM

The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes No

As of May 3, 2024, 115,572,774 shares of the registrant’s common stock, $0.0001 par value, were outstanding.

Latham Group, Inc.

Condensed Consolidated Balance Sheets

(in thousands, except share and per share data)

(unaudited)

March 30,

December 31,

    

2024

    

2023

Assets

Current assets:

 

  

 

  

Cash

$

43,811

$

102,763

Trade receivables, net

 

73,944

 

30,407

Inventories, net

 

95,151

 

97,137

Income tax receivable

 

1,411

 

983

Prepaid expenses and other current assets

 

6,996

 

7,327

Total current assets

 

221,313

 

238,617

Property and equipment, net

 

112,795

 

113,014

Equity method investment

 

26,341

 

25,940

Deferred tax assets

 

7,310

 

7,485

Operating lease right-of-use assets

28,696

30,788

Goodwill

 

130,987

 

131,363

Intangible assets, net

 

275,876

 

282,793

Other assets

5,294

5,003

Total assets

$

808,612

$

835,003

Liabilities and Stockholders’ Equity

 

  

 

  

Current liabilities:

 

  

 

  

Accounts payable

$

25,022

$

17,124

Accounts payable – related party

 

 

8

Current maturities of long-term debt

 

3,250

 

21,250

Current operating lease liabilities

6,823

7,133

Accrued expenses and other current liabilities

 

35,781

 

40,691

Total current liabilities

 

70,876

 

86,206

Long-term debt, net of discount, debt issuance costs, and current portion

 

279,531

 

279,951

Deferred income tax liabilities, net

 

40,088

 

40,088

Non-current operating lease liabilities

22,963

24,787

Other long-term liabilities

 

3,386

 

4,771

Total liabilities

$

416,844

$

435,803

Commitments and contingencies

 

  

 

  

Stockholders’ equity:

 

  

 

  

Preferred stock, $0.0001 par value; 100,000,000 shares authorized as of both March 30, 2024 and December 31, 2023; no shares issued and outstanding as of both March 30, 2024 and December 31, 2023

Common stock, $0.0001 par value; 900,000,000 shares authorized as of March 30, 2024 and December 31, 2023; 115,389,689 and 114,871,782 shares issued and outstanding, as of March 30, 2024 and December 31, 2023, respectively

 

11

 

11

Additional paid-in capital

 

460,927

 

459,684

Accumulated deficit

 

(64,820)

 

(56,956)

Accumulated other comprehensive loss

 

(4,350)

 

(3,539)

Total stockholders’ equity

 

391,768

 

399,200

Total liabilities and stockholders’ equity

$

808,612

$

835,003

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

4

Latham Group, Inc.

Condensed Consolidated Statements of Operations

(in thousands, except share and per share data)

(unaudited)

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

   

Net sales

$

110,629

$

137,719

Cost of sales

 

80,040

 

104,349

Gross profit

 

30,589

 

33,370

Selling, general, and administrative expense

 

26,250

 

33,057

Amortization

 

6,412

 

6,632

Loss from operations

 

(2,073)

 

(6,319)

Other expense:

 

  

 

  

Interest expense, net

 

4,982

 

10,804

Other expense, net

 

1,586

 

210

Total other expense, net

 

6,568

 

11,014

Earnings from equity method investment

1,309

37

Loss before income taxes

 

(7,332)

 

(17,296)

Income tax expense (benefit)

 

532

 

(2,928)

Net loss

$

(7,864)

$

(14,368)

Net loss per share attributable to common stockholders:

 

  

 

  

Basic

$

(0.07)

$

(0.13)

Diluted

$

(0.07)

$

(0.13)

Weighted-average common shares outstanding – basic and diluted

 

  

 

  

Basic

 

115,038,929

 

112,102,198

Diluted

 

115,038,929

 

112,102,198

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5

Latham Group, Inc.

Condensed Consolidated Statements of Comprehensive Loss

(in thousands)

(unaudited)

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

   

Net loss

$

(7,864)

$

(14,368)

Other comprehensive loss, net of tax:

 

  

 

  

Foreign currency translation adjustments

 

(811)

 

(144)

Total other comprehensive loss, net of tax

 

(811)

 

(144)

Comprehensive loss

$

(8,675)

$

(14,512)

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

6

Latham Group, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share amounts)

(unaudited)

    

    

    

    

    

Accumulated 

    

Additional

Other

Total

 Paid-in 

 Accumulated

 Comprehensive

 Stockholders'

Shares

Amount

Capital

 Deficit

Loss

 Equity

Balances at December 31, 2022

 

114,667,975

$

11

$

440,880

$

(54,568)

$

(3,533)

$

382,790

Net loss

 

 

 

 

(14,368)

 

 

(14,368)

Foreign currency translation adjustments

 

 

 

 

 

(144)

 

(144)

Issuance of common stock upon release of restricted stock units

22,078

Stock-based compensation expense

 

 

 

6,769

 

 

 

6,769

Balances at April 1, 2023

 

114,690,053

$

11

$

447,649

$

(68,936)

$

(3,677)

$

375,047

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

7

Latham Group, Inc.

Condensed Consolidated Statements of Stockholders’ Equity

(in thousands, except share amounts)

(unaudited)

    

    

    

    

    

Accumulated 

    

Additional

Other

Total

 Paid-in 

 Accumulated

 Comprehensive

 Stockholders'

Shares

Amount

Capital

 Deficit

Loss

 Equity

Balances at December 31, 2023

 

114,871,782

$

11

$

459,684

$

(56,956)

$

(3,539)

$

399,200

Net loss

 

 

 

 

(7,864)

 

 

(7,864)

Foreign currency translation adjustments

 

 

 

 

 

(811)

 

(811)

Issuance of common stock upon release of restricted stock units

517,907

Stock-based compensation expense

 

 

 

1,243

 

 

 

1,243

Balances at March 30, 2024

 

115,389,689

$

11

$

460,927

$

(64,820)

$

(4,350)

$

391,768

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

8

Latham Group, Inc.

Condensed Consolidated Statements of Cash Flows

(in thousands)

(unaudited)

Fiscal Quarter Ended

March 30,

April 1,

2024

    

2023

Cash flows from operating activities:

Net loss

$

(7,864)

$

(14,368)

Adjustments to reconcile net loss to net cash used in operating activities:

 

  

 

  

Depreciation and amortization

 

10,374

 

9,258

Amortization of deferred financing costs and debt discount

 

430

 

430

Non-cash lease expense

 

1,780

 

1,877

Change in fair value of interest rate swaps

 

(1,804)

 

4,866

Stock-based compensation expense

 

1,243

 

6,769

Bad debt expense

1,299

1,700

Other non-cash, net

1,757

860

Earnings from equity method investment

(1,309)

(37)

Distributions received from equity method investment

908

Changes in operating assets and liabilities:

 

  

 

  

Trade receivables

 

(44,895)

 

(55,286)

Inventories

 

1,648

 

15,615

Prepaid expenses and other current assets

 

467

 

(593)

Income tax receivable

 

(428)

 

(2,816)

Other assets

(146)

(1,225)

Accounts payable

 

8,179

 

20,947

Accrued expenses and other current liabilities

 

(5,987)

 

(3,190)

Other long-term liabilities

 

(164)

 

717

Net cash used in operating activities

 

(34,512)

 

(14,476)

Cash flows from investing activities:

 

  

 

  

Purchases of property and equipment

 

(5,345)

 

(9,942)

Net cash used in investing activities

 

(5,345)

 

(9,942)

Cash flows from financing activities:

 

  

 

  

Payments on long-term debt borrowings

 

(18,813)

 

(813)

Proceeds from borrowings on revolving credit facility

48,000

Repayments of finance lease obligations

(189)

(101)

Net cash (used in) provided by financing activities

 

(19,002)

 

47,086

Effect of exchange rate changes on cash

 

(93)

 

(278)

Net (decrease) increase in cash

 

(58,952)

 

22,390

Cash at beginning of period

 

102,763

 

32,626

Cash at end of period

$

43,811

$

55,016

Supplemental cash flow information:

 

  

 

  

Cash paid for interest

$

9,513

$

5,123

Income taxes paid, net

39

637

Supplemental disclosure of non-cash investing and financing activities:

 

 

  

Purchases of property and equipment included in accounts payable and accrued expenses

$

426

$

5,849

Capitalized internal-use software included in accounts payable – related party

359

Right-of-use operating and finance lease assets obtained in exchange for lease liabilities

198

1,625

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

9

Notes to Condensed Consolidated Financial Statements 

1. NATURE OF THE BUSINESS

Latham Group, Inc. (the “Company”) wholly owns Latham Pool Products, Inc. (“Latham Pool Products”) (together, “Latham”), a designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand. Latham offers a portfolio of in-ground swimming pools and related products, including pool liners and pool covers.

Stock Split, Initial Public Offering and Reorganization

On April 13, 2021, the Company’s certificate of incorporation was amended and restated. On April 13, 2021, the Company effected a 109,673.709-for-one stock split of its issued and outstanding shares of common stock. Accordingly, all share and per share data included in these condensed consolidated financial statements and notes thereto have been adjusted retroactively to reflect the impact of the amended and restated certificate of incorporation and the stock split.

On April 27, 2021, the Company completed its initial public offering (the “IPO”), pursuant to which it issued and sold 23,000,000 shares of common stock, inclusive of 3,000,000 shares sold by the Company pursuant to the full exercise of the underwriters’ option to purchase additional shares. The aggregate net proceeds received by the Company from the IPO were $399.3 million, after deducting underwriting discounts and commissions and other offering costs.

Prior to the closing of the Company’s IPO, the Company’s parent entity, Latham Investment Holdings, L.P., merged with and into Latham Group, Inc.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). The Company’s unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Unaudited Interim Financial Information

The unaudited condensed consolidated balance sheet at December 31, 2023 was derived from audited financial statements but does not include all disclosures required by GAAP. The accompanying unaudited condensed consolidated financial statements as of March 30, 2024 and for the fiscal quarters ended March 30, 2024 and April 1, 2023, respectively, have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with Latham Group, Inc.’s audited consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2023 included in the Company’s 2023 Annual Report on Form 10-K, filed with the SEC on March 13, 2024 (the “Annual Report”). In the opinion of management, all adjustments, consisting only of normal recurring adjustments necessary for a fair statement of these condensed consolidated financial statements, have been included. The Company’s results of operations for the fiscal quarter ended March 30, 2024 are not necessarily indicative of the results of operations that may be expected for the fiscal year ending December 31, 2024 or other interim periods thereof.

Use of Estimates

The preparation of the Company’s condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The Company bases its estimates on historical experience, known trends, and other market-specific relevant factors that it believes to be reasonable under the circumstances. Estimates are evaluated on an ongoing basis and revised as there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known.

10

Reclassifications

Certain prior period balances have been reclassified to conform to the current period presentation in the condensed consolidated financial statements and the accompanying notes.

Seasonality

Although the Company generally has demand for its products throughout the fiscal year, its business is seasonal and weather is one of the principal external factors affecting the business. Historically, net sales and net income are highest (or net loss is lowest) during the second and third fiscal quarters, representing the peak months of swimming pool use, pool installation, and remodeling and repair activities. Severe weather may also affect net sales in all periods.

Significant Accounting Policies

Refer to the Annual Report for a discussion of the Company’s significant accounting policies, as updated below.

Recently Issued Accounting Pronouncements

The Company qualifies as “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 and has elected to “opt in” to the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company will adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and will do so until such time that the Company either (i) irrevocably elects to “opt out” of such extended transition period or (ii) no longer qualifies as an emerging growth company. The Company may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for private companies.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which improves financial reporting by requiring disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful analysis. For all entities, ASU 2023-07 is effective for fiscal years beginning after December 15, 2023. The amendments should be applied retrospectively to all prior periods presented in the financial statements, with early adoption permitted. The Company is currently evaluating ASU 2023-07 and its potential impact on the notes to the condensed consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), in an effort to enhance the transparency and decision usefulness of income tax disclosures. For all entities, ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The amendments should be applied prospectively with retrospective application permitted. Early adoption is also permitted. The Company is currently evaluating ASU 2023-09 and its potential impact on the notes to the condensed consolidated financial statements.

In March 2024, the FASB issued ASU 2024-01, Compensation – Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards (“ASU 2024-01”), which improves financial reporting by providing clarity on when an entity should apply the scope guidance in paragraph 718-10-15-3. For all public entities, ASU 2024-01 is effective for fiscal years beginning after December 15, 2024. The amendments should be applied retrospectively to all prior periods presented in the financial statements, with early adoption permitted. The Company is currently evaluating ASU 2024-01 and its potential impact on the notes to the condensed consolidated financial statements.

3. FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value.

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Inputs, other than quoted prices in active markets, that are observable either directly or indirectly.

11

Level 3 — Unobservable inputs that reflect the Company’s own assumptions incorporated into valuation techniques. These valuations require significant judgment.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. When there is more than one input at different levels within the hierarchy, the fair value is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Assessment of the significance of a particular input to the fair value measurement in its entirety requires substantial judgment and consideration of factors specific to the asset or liability. Level 3 inputs are inherently difficult to estimate. Changes to these inputs can have significant impact on fair value measurements. Assets and liabilities measured at fair value using Level 3 inputs are based on one or more of the following valuation techniques: market approach, income approach or cost approach. There were no transfers between fair value measurement levels during the fiscal quarters ended March 30, 2024 and April 1, 2023.

Assets and liabilities measured at fair value on a nonrecurring basis

The Company’s non-financial assets such as goodwill, intangible assets, and property and equipment are measured at fair value upon acquisition and remeasured to fair value when an impairment charge is recognized. Such fair value measurements are based predominantly on Level 2 and Level 3 inputs.

Fair value of financial instruments

The Company considers the carrying amounts of cash, trade receivables, prepaid expenses and other current assets, accounts payable, and accrued expenses and other current liabilities to approximate fair value because of the short-term maturities of these instruments.

Term loan

The Company’s term loan (see Note 6) is carried at amortized cost; however, the Company estimates the fair value of the term loan for disclosure purposes. The fair value of the term loan is determined using inputs based on observable market data of a non-public exchange, which are classified as Level 2 inputs. The following table sets forth the carrying amount and fair value of its term loan (in thousands):

March 30, 2024

December 31, 2023

Carrying

Estimated

Carrying

Estimated

    

Value

    

Fair Value

    

Value

    

Fair Value

Term Loan

$

282,781

$

277,832

$

301,201

$

289,153

Interest rate swap

The Company estimates the fair value of interest rate swaps (see Note 6) on a fiscal quarterly basis using Level 2 inputs, including the forward SOFR curve. The fair value is estimated by comparing (i) the present value of all future monthly fixed rate payments versus (ii) the variable payments based on the forward SOFR curve. As of March 30, 2024 and December 31, 2023, the fair value of the Company’s interest rate swap was an asset of $0.6 million and a liability of $1.2 million, respectively, which were recorded within other assets and other long-term liabilities on the condensed consolidated balance sheets, respectively.

4. GOODWILL AND INTANGIBLE ASSETS, NET

Goodwill

The carrying amount of goodwill as of March 30, 2024 and as of December 31, 2023 was $131.0 million and $131.4 million, respectively. The change in the carrying value during the fiscal quarter ended March 30, 2024 was solely because of fluctuations in foreign currency exchange rates.

12

Intangible Assets

Intangible assets, net as of March 30, 2024 consisted of the following (in thousands):

March 30, 2024

Gross 

Foreign 

Carrying 

Currency 

Accumulated 

Net 

    

Amount

    

Translation

    

Amortization

    

Amount

Trade names and trademarks

$

148,100

$

(251)

$

31,233

$

116,616

Patented technology

 

16,126

 

(4)

 

9,111

 

7,011

Technology

13,000

2,023

10,977

Pool designs

 

13,628

 

(124)

 

3,207

 

10,297

Franchise relationships

 

1,187

 

 

1,187

 

Dealer relationships

 

197,376

 

(1)

 

66,400

 

130,975

Order backlog

1,600

1,600

Non-competition agreements

 

2,476

 

 

2,476

 

$

393,493

$

(380)

$

117,237

$

275,876

The Company recognized $6.4 million of amortization expense related to intangible assets during the fiscal quarter ended March 30, 2024. The Company recognized $6.6 million of amortization expense related to intangible assets during the fiscal quarter ended April 1, 2023.

Intangible assets, net as of December 31, 2023 consisted of the following (in thousands):

December 31, 2023

Gross 

Foreign 

Carrying 

Currency 

Accumulated 

Net 

    

Amount

    

Translation

    

Amortization

    

Amount

Trade names and trademarks

$

148,100

$

72

$

29,583

$

118,589

Patented technology

 

16,126

 

1

 

8,713

 

7,414

Technology

13,000

1,806

11,194

Pool designs

 

13,628

 

35

 

2,973

 

10,690

Franchise relationships

 

1,187

 

 

1,187

 

Dealer relationships

 

197,376

 

 

62,470

 

134,906

Order backlog

1,600

1,600

Non-competition agreements

 

2,476

 

 

2,476

 

$

393,493

$

108

$

110,808

$

282,793

The Company estimates that amortization expense related to definite-lived intangible assets will be as follows in each of the next five years and thereafter (in thousands):

Estimated Future 

Amortization 

Year Ended

    

Expense

Remainder of fiscal year 2024

$

19,282

2025

 

25,551

2026

 

25,551

2027

 

25,551

2028

 

24,593

Thereafter

 

155,348

$

275,876

13

5. INVENTORIES, NET

Inventories, net consisted of the following (in thousands):

    

March 30, 2024

    

December 31, 2023

Raw materials

$

53,145

$

55,081

Finished goods

 

42,006

 

42,056

$

95,151

$

97,137

6. LONG-TERM DEBT

The components of the Company’s outstanding long-term debt obligations consisted of the following (in thousands):

    

March 30, 2024

    

December 31, 2023

Term Loan

$

290,500

$

309,313

Revolving Credit Facility

Less: Unamortized discount and debt issuance costs

 

(7,719)

 

(8,112)

Total debt

 

282,781

 

301,201

Less: Current portion of long-term debt

 

(3,250)

 

(21,250)

Total long-term debt

$

279,531

$

279,951

On February 23, 2022, Latham Pool Products entered into an agreement (the “Credit Agreement”) with Barclays Bank PLC, which provides a senior secured multicurrency revolving line of credit (the “Revolving Credit Facility”) in an initial principal amount of $75.0 million and a U.S. Dollar senior secured term loan facility (the “Term Loan”) in an initial principal amount of $325.0 million.

As of March 30, 2024, the Company was in compliance with all financial covenants under the Credit Agreement.

Revolving Credit Facility

The Revolving Credit Facility may be utilized to finance ongoing general corporate and working capital needs and permits Latham Pools Products to borrow loans in U.S. Dollars, Canadian Dollars, Euros and Australian Dollars. The Revolving Credit Facility matures on February 23, 2027. Loans outstanding under the Revolving Credit Facility denominated in U.S. Dollars and Canadian Dollars bear interest, at the borrower’s option, at a rate per annum based on Term SOFR or CDO (each, as defined in the Credit Agreement), as applicable, plus a margin of 3.50%, or at a rate per annum based on the Base Rate or the Canadian Prime Rate (each, as defined in the Credit Agreement), plus a margin of 2.50%. Loans outstanding under the Revolving Credit Facility denominated in Euros or Australian Dollars bear interest based on EURIBOR or the AUD Rate (each, as defined in the Credit Agreement), respectively, plus a margin of 3.50%. A commitment fee accrues on any unused portion of the commitments under the Revolving Credit Facility. The commitment fee is due and payable quarterly in arrears, and initially was 0.375% per annum and thereafter accrues at a rate per annum ranging from 0.25% to 0.50%, depending on the First Lien Net Leverage Ratio (as defined in the Credit Agreement, the “First Lien Net Leverage Ratio”). Borrowings under the Revolving Credit Facility are due at maturity.

The Company incurred debt issuance costs of $0.8 million related to the Revolving Credit Facility. The debt issuance costs were recorded within other assets on the condensed consolidated balance sheet as of the applicable period and are being amortized over the life of the Revolving Credit Facility.

The Company is required to meet certain financial covenants in connection with the Revolving Credit Facility, including maintaining specific liquidity measurements. There are also negative covenants, including certain restrictions on the Company’s and its subsidiaries’ ability to incur additional indebtedness, create liens, make investments, consolidate, or merge with other entities, enter into transactions with affiliates, make prepayments with respect to certain indebtedness, make dividend payments, loans, or advances to the Company, declare dividends and make restricted payments and other distributions.

As of March 30, 2024, there were no outstanding borrowings on the Revolving Credit Facility and $75.0 million was available for future borrowing.

14

Term Loan

The Term Loan matures on February 23, 2029. The Term Loan bears interest, at the borrower’s option, at a rate per annum based on Term SOFR (as defined in the Credit Agreement), plus a margin ranging from 3.75% to 4.00%, depending on the First Lien Net Leverage Ratio, or based on the Base Rate (as defined in the Credit Agreement), plus a margin ranging from 2.75% to 3.00%, depending on the First Lien Net Leverage Ratio. The Term Loan is subject to scheduled quarterly amortization payments of $812,500, equal to 0.25% of the initial principal amount of the Term Loan. The Credit Agreement contains customary mandatory prepayment provisions for the Term Loan, including requirements to make mandatory prepayments with 50% of any excess cash flow and with 100% of the net cash proceeds from the incurrence of indebtedness not otherwise permitted to be incurred by the covenants, asset sales, and casualty and condemnation events, in each case, subject to customary exceptions.

During the quarter ended March 30, 2024, the Company made a payment of $18.0 million.

Outstanding borrowings as of March 30, 2024 were $282.8 million, net of unamortized discount and debt issuance costs of $7.7 million. In connection with the Term Loan, the Company is subject to various negative, reporting, financial, and other covenants, including maintaining specific liquidity measurements.

As of March 30, 2024, the unamortized debt issuance costs and discount on the Term Loan were $4.3 million and $3.4 million, respectively. The effective interest rate was 9.89% at March 30, 2024, including the impact of the Company’s interest rate swaps.

Interest Rate Risk

Interest rate risk associated with the Credit Agreement is mitigated partially through interest rate swaps.

The Company executed an interest rate swap on April 30, 2020. The swap had an effective date of May 18, 2020 and a termination date of May 18, 2023. In February 2022, the Company amended its interest rate swap to change the index rate from LIBOR to SOFR in connection with the entry into the Credit Agreement. Under the terms of the amended swap, the Company fixed its SOFR borrowing rate at 0.496% on a notional amount of $200.0 million. The interest rate swap was not designated as a hedging instrument for accounting purposes (see Note 3).

Additionally, the Company entered into an interest rate swap that was executed on March 10, 2023. The swap has an effective date of May 18, 2023 and a termination date of May 18, 2026. Under the terms of the swap, the Company fixed its SOFR borrowing rate at 4.3725% on a notional amount of $161.0 million. The interest rate swap is not designated as a hedging instrument for accounting purposes (see Note 3).

Debt Maturities

Principal payments due on the outstanding debt, excluding the Revolving Credit Facility, in the next five fiscal years, excluding any potential payments based on excess cash flow, are as follows (in thousands):

Year Ended

Term Loan

Remainder of fiscal year 2024

    

$

2,438

2025

 

3,250

2026

 

3,250

2027

 

3,250

2028

3,250

Thereafter

 

275,062

$

290,500

Guarantees

The obligations under the Credit Agreement are guaranteed by certain wholly owned subsidiaries (the “Guarantors”) of the Company as defined in the security agreement. The obligations under the Credit Agreement are secured by substantially all of the Guarantors’ tangible and intangible assets, including their accounts receivables, equipment, intellectual property, inventory, cash and cash equivalents, deposit accounts, and security accounts. The Credit Agreement also restricts payments and other distributions unless certain conditions are met, which could restrict the Company’s ability to pay dividends.

15

7. PRODUCT WARRANTIES

The warranty reserve activity consisted of the following (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Balance at the beginning of the fiscal year

$

3,161

$

3,990

Adjustments to reserve

 

537

 

354

Less: Settlements made (in cash or in kind)

 

(679)

 

(761)

Balance at the end of the fiscal quarter

$

3,019

$

3,583

8. LEASES

For leases with initial terms greater than 12 months, the Company considers these right-of-use assets and records the related asset and obligation at the present value of lease payments over the term. For leases with initial terms equal to or less than 12 months, the Company does not consider them as right-of-use assets and instead considers them short-term lease costs that are recognized on a straight-line basis over the lease term. The Company’s leases may include escalation clauses, renewal options, and/or termination options that are factored into the Company’s determination of lease term and lease payments when it is reasonably certain the option will be exercised. The Company elected to take the practical expedient and not separate lease and non-lease components of contracts. The Company estimates an incremental borrowing rate to discount the lease payments based on information available at lease commencement because the implicit rate of the lease is generally not known.

The Company leases manufacturing facilities, office space, land, and certain vehicles and equipment under operating leases. The Company also leases certain vehicles and equipment under finance leases. The Company determines if an arrangement is a lease at inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.

The components of lease expense for the fiscal quarters ended March 30, 2024 and April 1, 2023 were as follows (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Operating lease expense

$

2,163

$

2,351

Finance lease amortization of assets

212

109

Finance lease interest on lease liabilities

84

52

Short-term lease expense

 

56

 

54

Variable lease expense

 

158

 

327

Total lease expense

$

2,673

$

2,893

Operating and finance lease right-of-use assets and lease-related liabilities as of March 30, 2024 and December 31, 2023 were as follows (in thousands):

March 30, 2024

December 31, 2023

Classification

Lease right-of-use assets:

Operating leases

$

28,696

$

30,788

Operating lease right-of-use assets

Finance leases

3,887

3,912

Other assets

Total lease right-of-use assets

$

32,583

$

34,700

Lease-related liabilities

Current

Operating leases

$

6,823

$

7,133

Current operating lease liabilities

Finance leases

782

746

Accrued expenses and other current liabilities

Non-current

Operating leases

22,963

24,787

Non-current operating lease liabilities

Finance leases

3,247

3,285

Other long-term liabilities

Total lease liabilities

$

33,815

$

35,951

16

The table below presents supplemental information related to leases as of March 30, 2024 and December 31, 2023:

    

March 30, 2024

December 31, 2023

Weighted-average remaining lease term (years)

Finance leases

5.0

5.2

Operating leases

5.6

5.7

Weighted-average discount rate

Finance leases

8.2

%

8.2

%

Operating leases

5.0

%

5.1

%

The table below presents supplemental information related to the cash flows for operating leases recorded on the condensed consolidated statements of cash flows (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows for operating leases

$

1,794

$

1,817

The following table summarizes maturities of operating lease liabilities as of March 30, 2024 (in thousands):

    

Operating Leases

Finance Leases

Total

Remainder of fiscal year 2024

$

6,260

$

813

$

7,073

2025

7,309

1,030

8,339

2026

5,805

934

6,739

2027

4,097

858

4,955

2028

3,111

845

3,956

Thereafter

7,637

436

8,073

Total lease payments

34,219

4,916

39,135

Less: Interest

(4,433)

(886)

(5,319)

Present value of lease liability

$

29,786

$

4,030

$

33,816

9. NET SALES

The following table sets forth the Company’s disaggregation of net sales by product line (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

In-ground Swimming Pools

$

59,832

$

78,612

Covers

 

26,868

 

32,745

Liners

 

23,929

 

26,362

$

110,629

$

137,719

10. INCOME TAXES

The effective income tax rate for the fiscal quarter ended March 30, 2024 was (7.2)% compared to 16.9% for the fiscal quarter ended April 1, 2023. The differences between the U.S. federal statutory income tax rate and our effective income tax rates for the fiscal quarter ended March 30, 2024 and the fiscal quarter ended April 1, 2023 were primarily attributable to the discrete impact of stock compensation expense for which there is no associated tax benefit.

17

11. STOCKHOLDERS’ EQUITY

Repurchase Program

On May 10, 2022, the Board of Directors of the Company approved a stock repurchase program (the “Repurchase Program”), which authorizes the Company to repurchase up to $100 million of the Company’s shares of common stock by May 2025. The Company may effect these repurchases in open market transactions, privately negotiated purchases, or other acquisitions. The Company is not obligated to repurchase any of its shares of its common stock under the Repurchase Program and the timing and amount of any repurchases will depend on market conditions, the Company’s stock price, alternative uses of capital, the terms of the Company’s debt instruments, and other factors.

As of March 30, 2024, $77.0 million remained available for share repurchases pursuant to the Repurchase Program. The Company did not repurchase any shares of its common stock during the fiscal quarter ended March 30, 2024. The Company accounts for the excess of the repurchase price over the par value of shares acquired as a reduction to additional paid-in capital.

12. STOCK-BASED COMPENSATION

On April 12, 2021, the Company’s stockholders approved the 2021 Omnibus Equity Incentive Plan (the “2021 Omnibus Equity Plan”), which became effective on April 22, 2021, upon pricing of its initial public offering. The 2021 Omnibus Equity Plan provides for the issuance of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance stock units and other stock-based and cash-based awards. The maximum grant date fair value of cash and equity awards that may be awarded to a non-employee director under the 2021 Omnibus Equity Plan during any one fiscal year, together with any cash fees paid to such non-employee director during such fiscal year, is $750,000.

On May 2, 2023, at the 2023 annual meeting of stockholders of the Company, the stockholders approved the first amendment (the “First Amendment”) to the 2021 Omnibus Equity Plan, which was previously approved by the Board of Directors of the Company. The First Amendment became effective upon stockholder approval, and included an increase by 8,000,000 shares of the share pool, i.e. the maximum number of shares of the Company’s common stock that may be issued pursuant to awards granted under the 2021 Omnibus Equity Plan.

Except as amended by the First Amendment, the other terms of the 2021 Omnibus Equity Plan remain in full force and effect. Subsequent to the First Amendment, the maximum aggregate number of shares reserved for issuance under the 2021 Omnibus Equity Plan is 21,170,212 shares.

The following table summarizes the Company’s stock-based compensation expense (in thousands):

Fiscal Quarter Ended

March 30, 2024

    

April 1, 2023

Cost of sales

$

$

426

Selling, general, and administrative

 

1,243

 

6,343

$

1,243

$

6,769

As of March 30, 2024, total unrecognized stock-based compensation expense related to all unvested stock-based awards was $13.3 million, which is expected to be recognized over a weighted-average period of 2.2 years.

Restricted Stock Awards

The following table represents the Company’s restricted stock awards activity during the fiscal quarter ended March 30, 2024:

Weighted-

Average Grant-

    

Shares

    

Date Fair Value

Outstanding at January 1, 2024

 

42,886

$

19.00

Granted

 

 

Vested

 

 

Forfeited

 

 

Outstanding at March 30, 2024

 

42,886

$

19.00

18

Restricted Stock Units

The following table represents the Company’s restricted stock units activity during the fiscal quarter ended March 30, 2024:

    

    

Weighted-

Average Grant-

Shares

Date Fair Value

Outstanding at January 1, 2024

 

2,235,479

$

3.60

Granted

 

2,282,336

 

2.87

Vested

 

(411,301)

 

3.94

Forfeited

 

(85,392)

 

2.93

Outstanding at March 30, 2024

 

4,021,122

$

3.17

Stock Options

The following table represents the Company’s stock option activity during the fiscal quarter ended March 30, 2024:

    

Weighted-

    

Weighted-

    

Average 

Average 

Exercise Price

Remaining 

Aggregate 

    

Shares

    

 per Share

    

Contract Term

    

Intrinsic Value

 

 

(in years)

(in thousands)

Outstanding at January 1, 2024

 

1,554,294

$

15.43

 

Granted

 

 

  

 

  

Exercised

 

 

 

  

 

  

Forfeited

 

(42,004)

 

16.92

 

  

 

  

Expired

(57,616)

17.78

Outstanding at March 30, 2024

 

1,454,674

$

15.30

 

7.58

$

Vested and expected to vest at March 30, 2024

 

1,454,674

$

15.30

 

7.58

$

Options exercisable at March 30, 2024

 

678,477

$

16.10

 

7.38

$

The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those stock options that had exercise prices lower than the fair value of the Company’s common stock.

Stock Appreciation Rights

During the fiscal quarter ended April 1, 2023, as a portion of the annual equity award grants to the Company’s executive officers, the Compensation Committee of the Board of Directors approved stock appreciation rights for an aggregate of 790,181 shares of the Company’s common stock, with a strike price of $3.24 per share. At the time of such approval, the Company did not have enough shares of the Company’s common stock in the share pool under the 2021 Omnibus Equity Plan to support such grant. As of April 1, 2023, the contingent grant of stock appreciation rights remained subject to stockholder approval of the First Amendment. On May 2, 2023, following stockholder approval of the First Amendment, the foregoing stock appreciation right awards became effective without condition.

19

The following table represents the Company’s stock appreciation rights activity during the fiscal quarter ended March 30, 2024:

    

Weighted-

    

Weighted-

    

Average 

Average 

Exercise Price

Remaining 

Aggregate 

    

Shares

    

 per Share

    

Contract Term

    

Intrinsic Value

 

 

(in years)

(in thousands)

Outstanding at January 1, 2024

 

755,802

$

3.16

 

Granted

 

 

  

 

  

Exercised

 

 

 

  

 

  

Forfeited

 

(49,342)

 

3.24

 

  

 

  

Outstanding at March 30, 2024

 

706,460

$

3.15

 

9.13

$

569,296

Vested and expected to vest at March 30, 2024

 

706,460

$

3.15

 

9.13

$

569,296

Stock appreciation rights exercisable at March 30, 2024

 

161,893

$

3.24

 

9.09

$

116,563

The aggregate intrinsic value of stock appreciation rights is calculated as the difference between the strike price of the stock appreciation rights and the fair value of the Company’s common stock for those stock appreciation rights that had strike prices lower than the fair value of the Company’s common stock.

No stock appreciation rights were granted under this plan during the fiscal quarter ended March 30, 2024.

Performance Stock Units

During the fiscal quarter ended March 30, 2024 the Compensation Committee of the Board of Directors approved the grant of performance stock units (“PSUs”) as a portion of the annual equity award to the Company’s executive officers for an aggregate of 427,145 shares of the Company’s common stock.

The PSUs will be earned at 0% to 200% of the target PSUs (with 100% of PSUs being earned at target performance, and linear interpolation between threshold and target and maximum performance) based on the Company’s achievement of Adjusted EBITDA, as defined in the award agreement, over a one-year performance period ending December 31, 2024. Any earned PSUs cliff vest on the third anniversary of the grant date. Adjusted EBITDA is considered a performance condition and the grant date fair value corresponds with management’s expectation of the probable outcome of the performance condition as of the grant date. The grant date fair value is determined based on the fair market value of the Company’s stock at market close on the grant date multiplied by the target number of shares subject to the award. The probability of achieving the performance criteria is assessed quarterly during the performance period. Compensation expense related to unvested PSUs is recognized ratably over the service period.

The following table represents the Company’s PSU activity during the fiscal quarter ended March 30, 2024:

    

 

Weighted-

 

Average 

 

Grant Date

    

Shares

    

 

Fair Value

 

 

Outstanding at January 1, 2024

 

$

Granted

 

427,145

2.87

Adjustment for expected performance achievement (1)

 

Forfeited

 

Outstanding at March 30, 2024 (2)

 

427,145

$

2.87

(1)Represents the adjustment to previously granted PSUs based on performance expectations as of the end of each respective fiscal year.
(2)An additional 427,145 PSUs could potentially be included if the maximum performance level of 200% is earned for all PSUs outstanding as of March 30, 2024.

20

13. NET LOSS PER SHARE

Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share data):

Fiscal Quarter Ended

    

    

March 30, 2024

    

April 1, 2023

Numerator:

  

  

Net loss attributable to common stockholders

$

(7,864)

$

(14,368)

Denominator:

 

  

 

  

Weighted-average common shares outstanding

 

Basic

115,038,929

112,102,198

Diluted

115,038,929

112,102,198

Net loss per share attributable to common stockholders:

Basic

$

(0.07)

$

(0.13)

Diluted

$

(0.07)

$

(0.13)

As of March 30, 2024 and December 31, 2023, 115,346,803 and 114,828,896 shares of common stock were issued and outstanding for accounting purposes, respectively.

The following table includes the number of shares that may be dilutive common shares in the future that were not included in the computation of diluted net loss per share because the effect was anti-dilutive:

    

    

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Restricted stock awards

 

42,886

 

2,576,219

Restricted stock units

 

24,146

 

500,751

Stock options

 

1,521,158

 

1,886,497

Stock appreciation rights

657,999

Performance stock units

75,937

14. RELATED PARTY TRANSACTIONS

BrightAI Services

Starting in 2020, BrightAI Corporation (“BrightAI”) has rendered services to the Company, for which the cost has been capitalized as internal-use software. A co-founder of BrightAI Services served on the Company’s Board of Directors from December 9, 2020 until his resignation on February 21, 2024. In December 2022, the Company executed an additional agreement with BrightAI for the provision of hardware to run the technology developed by BrightAI and the Company. The Company had no material transactions with BrightAI during the quarters ended March 30, 2024 and April 1, 2023. As of December 31, 2023, the Company had no accounts payable related to BrightAI.

15. RESTRUCTURING COSTS

During the second and third fiscal quarters of 2023, the Company initiated an additional plan focused on efforts to improve efficiencies and decrease costs. The plan involved a reduction in the Company’s workforce as well as closures of various manufacturing facilities. The Company had an exit or disposal cost related liability of $0.1 million as of March 30, 2024 and $0.2 million as of December 31, 2023.

21

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion and analysis of our financial condition and results of operations in conjunction with our condensed consolidated financial statements and related notes appearing elsewhere in this Quarterly Report on Form 10-Q and our 2023 Annual Report on Form 10-K filed with the Securities and Exchange Commission, or SEC, on March 13, 2024 (the “Annual Report”).

Cautionary Note Regarding Forward-Looking Statements

Certain statements in this report constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this report other than statements of historical fact may constitute forward-looking statements, including statements regarding our future operating results and financial position, our business strategy and plans, business and market trends, our objectives for future operations, macroeconomic and geopolitical conditions, the implementation of our cost reduction plans and expected annualized cost savings, the implementation of our digital transformation and lean manufacturing activities, a potential non-cash impairment charge for goodwill, and the sufficiency of our cash balances, working capital and cash generated from operating, investing, and financing activities for our future liquidity and capital resource needs. These forward-looking statements are generally identified by the use of forward-looking terminology, including the terms “anticipate,” “believe,” “confident,” “continue,” “could,” “estimate,” “expect,” “intend,” “likely,” “may,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and, in each case, their negative or other various or comparable terminology. These statements involve known and unknown risks, uncertainties, assumptions and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements, including those set forth under “Risk Factors,” “Management's Discussion and Analysis of Financial Condition and Results of Operations” and elsewhere in the Annual Report and as described in other subsequent reports we file or furnish with the SEC, including elsewhere in this Quarterly Report on Form 10-Q. For similar reasons, our past results may not be a reliable indicator of future performance and trends. We encourage you to read this report and our other filings with the SEC carefully. You also should be aware that these risk factors and other information do not describe every risk that we face. New emerging risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business, financial condition, results of operations and cash flows. We operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. Although we believe that the expectations reflected in the forward-looking statements are reasonable and our expectations based on third-party information and projections are from sources that management believes to be reputable, we cannot guarantee future results, levels of activities, performance, or achievements.

These forward-looking statements reflect our views with respect to future events as of the date of this Quarterly Report on Form 10-Q or the date specified herein, and we have based these forward-looking statements on our current expectations and projections about future events and trends. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Except as required by law, we undertake no obligation to update or review publicly any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this Quarterly Report on Form 10-Q. We anticipate that subsequent events and developments will cause our views to change. Our forward-looking statements further do not reflect the potential impact of any future acquisitions, merger, dispositions, joint ventures, or investments we may undertake. We qualify all of our forward-looking statements by these cautionary statements.

22

Overview

We are the largest designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand. We hold the leading position in North America in every product category in which we compete. It is our view that we are the most sought-after brand in the pool industry and the only pool company that has established a direct relationship with the homeowner. We are Latham, The Pool Company.

With an operating history that spans over 65 years, we offer the industry’s broadest portfolio of pools and related products, including in-ground swimming pools, pool liners, and pool covers.

We have a heritage of innovation. In an industry that has traditionally marketed on a business-to-business basis (pool manufacturer to dealer), we pioneered the first “direct-to-homeowner” digital and social marketing strategy that has transformed the homeowner’s purchase journey. Through this marketing strategy, we are able to create demand for our pools and to provide high quality, purchase-ready consumer leads to our dealer partners.

Partnership with our dealers is integral to our collective success, and we have enjoyed long-tenured relationships averaging over 14 years. We support our dealer network with business development tools, co-branded marketing programs, and in-house training, as well as an operations platform consisting of approximately 1,800 employees across approximately 24 locations.

The full resources of our company are dedicated to designing and manufacturing high-quality pool products, with the homeowner in mind, and positioning ourselves as a value-added partner to our dealers.

We conduct our business as one operating and reportable segment that designs, manufactures, and markets in-ground swimming pools, pool liners, and pool covers.

Recent Developments

Highlights for the fiscal quarter ended March 30, 2024

Decrease in net sales of 19.7%, or $27.1 million, to $110.6 million for the fiscal quarter ended March 30, 2024, compared to $137.7 million for the fiscal quarter ended April 1, 2023.
Decrease in net loss of $6.5 million to $7.9 million and representing a 7.1% net loss margin for the fiscal quarter ended March 30, 2024, compared to net loss of $14.4 million for the fiscal quarter ended April 1, 2023.
Increase in Adjusted EBITDA (as defined below) of $1.3 million to $12.3 million for the fiscal quarter ended March 30, 2024, compared to $11.0 million for the fiscal quarter ended April 1, 2023.

23

Business Update

Ongoing macroeconomic challenges have impacted and are expected to continue to impact consumer spending and demand. As anticipated, this resulted in a decline in U.S. new in-ground residential pool installations in the first quarter of 2024, mainly driven by lower packaged pool demand. Fiberglass products continue to show strength relative to packaged pools.

We continue to make progress executing our strategy to drive adoption and awareness of fiberglass pools and automatic safety covers and gain additional operating efficiencies through value engineering and lean manufacturing initiatives. We continue to take a disciplined approach to capital investments, with the focus on the completion of previously announced projects such as our recent multi-year capital plan to invest in our facilities.

We have responded to economic uncertainty by implementing cost reduction programs and lean manufacturing initiatives that structurally reduce our cost basis, while maintaining capacity. We expect to realize an additional $4.8 million of annualized savings during 2024 from plans initiated in the second and third quarters of 2023, with $2.7 million realized in the first quarter and the remainder expected to be realized in the second quarter.

Key Performance Indicators

Net Sales

We derive our revenue from the design, manufacture, and sale of in-ground swimming pools, pool covers, and pool liners. We sell fiberglass pools, which are one-piece manufactured fiberglass pools that are ready to be installed in a consumer’s backyard, and custom vinyl pools, which are manufactured pools that are made out of non-corrosive steel, aluminum, or composite polymer frame, on top of which a vinyl liner is installed. We sell liners for the interior surface of vinyl pools (including pools that were not manufactured by us). We also sell all-season covers, which are winterizing mesh or solid pool covers that protect pools against debris and cold or inclement weather, and automatic safety covers for pools that can be operated with a switch.

Our sales are made through one-step and two-step business-to-business distribution channels. In our one-step distribution channel, we sell our products directly to dealers who, in turn, sell our products to consumers. In our two-step distribution channel, we sell our products to distributors who warehouse our products and sell them on to dealers, who ultimately sell our products to consumers.

Each product shipped is considered to be one performance obligation. With the exception of our extended service warranties and our custom product contracts, we recognize our revenue when control of our promised goods is transferred to our customers (dealer in one-step distribution channel or distributor in two-step distribution channel), either upon shipment or arrival at our customer’s destination depending upon the terms of the purchase order. Sales are recognized net of any estimated rebates, returns, allowances, cash discounts, or other sales incentives. Revenue that is derived from our extended service warranties, which are separately priced and sold, is recognized over the term of the contracts. Revenue from custom products is recognized over time utilizing an input method that compares the cost of cumulative work-in-process to date to the most current estimates for the entire cost of the performance obligation.

Gross Margin

Gross margin is gross profit as a percentage of our net sales. Gross margin depends upon several factors, such as the prices we charge buyers, changes in prices of raw materials, the volume and relative sales mix among product lines, and plant performance, among other factors. Gross margin is also impacted by the costs of distribution and occupancy costs, which can vary.

Our gross profit is primarily variable in nature and generally follows changes in net sales. The components of our cost of sales may not be comparable to the components of cost of sales or similar measures of other companies. As a result, our gross profit and gross margin may not be comparable to similar data made available by other companies.

Adjusted EBITDA and Adjusted EBITDA Margin

Adjusted EBITDA and Adjusted EBITDA margin are key metrics used by management and our Board of Directors to assess our financial performance. Adjusted EBITDA and Adjusted EBITDA margin are also frequently used by analysts, investors, and other interested parties to evaluate companies in our industry, when considered alongside other GAAP measures. We use Adjusted EBITDA and Adjusted EBITDA margin to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, to utilize as a significant performance metric in our incentive compensation plans, and to compare our

24

performance against that of other companies using similar measures. We have presented Adjusted EBITDA and Adjusted EBITDA margin solely as supplemental disclosures because we believe they allow for a more complete analysis of results of operations and assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance, such as (i) depreciation and amortization, (ii) interest expense, (iii) income tax (benefit) expense, (iv) loss (gain) on sale and disposal of property and equipment, (v) restructuring charges, (vi) stock-based compensation expense, (vii) unrealized (gains) losses on foreign currency transactions, (viii) strategic initiative costs, (ix) acquisition and integration related costs, (x) the Odessa fire and other such unusual events and (xi) other.

Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP financial measures and should not be considered as alternatives to net income (loss) as a measure of financial performance or any other performance measure derived in accordance with GAAP, and they should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA and Adjusted EBITDA margin, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. There can be no assurance that we will not modify the presentation of Adjusted EBITDA and Adjusted EBITDA margin in the future, and any such modification may be material. Our presentation of Adjusted EBITDA and Adjusted EBITDA margin should not be construed to imply that our future results will be unaffected by any such adjustments. In addition, other companies, including companies in our industry, may not calculate Adjusted EBITDA and Adjusted EBITDA margin at all or may calculate Adjusted EBITDA and Adjusted EBITDA margin differently and accordingly, are not necessarily comparable to similarly entitled measures of other companies, which reduces the usefulness of Adjusted EBITDA and Adjusted EBITDA margin as tools for comparison.

For a discussion of Adjusted EBITDA and Adjusted EBITDA margin and the limitations on their use, and the reconciliation of Adjusted EBITDA to net loss, the most directly comparable GAAP financial measure, and our calculation of Adjusted EBITDA margin see “— Non-GAAP Financial Measures” below.

25

Results of Operations

Fiscal Quarter Ended March 30, 2024 Compared to Fiscal Quarter Ended April 1, 2023

The following table summarizes our results of operations for the fiscal quarter ended March 30, 2024 and April 1, 2023 (dollars in thousands):

Fiscal Quarter Ended

 

% of Net

% of Net

Change  

Change in %  

 

    

March 30, 2024

    

Sales

    

April 1, 2023

    

Sales

    

Amount

    

of Net Sales

 

(dollars in thousands)

 

Net sales

$

110,629

100.0

%

$

137,719

100.0

%

$

(27,090)

0.0

%

Cost of sales

 

80,040

 

72.3

%  

 

104,349

 

75.8

%  

 

(24,309)

 

(3.5)

%

Gross profit

 

30,589

 

27.7

%  

 

33,370

 

24.2

%  

 

(2,781)

 

3.5

%

Selling, general, and administrative expense

 

26,250

 

23.8

%  

 

33,057

 

24.0

%  

 

(6,807)

 

(0.2)

%

Amortization

 

6,412

 

5.8

%  

 

6,632

 

4.8

%  

 

(220)

 

1.0

%

Loss from operations

 

(2,073)

 

(1.9)

%  

 

(6,319)

 

(4.6)

%  

 

4,246

 

2.7

%

Other expense:

 

 

 

 

 

 

Interest expense, net

 

4,982

 

4.5

%  

 

10,804

 

7.8

%  

 

(5,822)

 

(3.3)

%

Other expense, net

 

1,586

 

1.4

%  

 

210

 

0.1

%  

 

1,376

 

1.3

%

Total other expense, net

 

6,568

 

5.9

%  

 

11,014

 

8.0

%  

 

(4,446)

 

(2.0)

%

Earnings from equity method investment

 

1,309

 

1.2

%  

 

37

 

0.0

%  

 

1,272

 

1.2

%

Loss before income taxes

 

(7,332)

 

(6.6)

%  

 

(17,296)

 

(12.6)

%  

 

9,964

 

6.0

%

Income tax expense (benefit)

 

532

 

0.5

%  

 

(2,928)

 

(2.1)

%  

 

3,460

 

2.6

%

Net loss

$

(7,864)

 

(7.1)

%  

$

(14,368)

 

(10.4)

%  

$

6,504

 

3.3

%

Adjusted EBITDA(a)

$

12,293

 

11.1

%  

$

11,033

 

8.0

%  

$

1,260

 

3.1

%

(a)Adjusted EBITDA is a non-GAAP measure. See “Non-GAAP Financial Measures” for a reconciliation to net loss, the most directly comparable GAAP measure, and for information regarding our use of Adjusted EBITDA.

Net Sales

Net sales were $110.6 million for the fiscal quarter ended March 30, 2024, compared to $137.7 million for the fiscal quarter ended April 1, 2023. The $27.1 million, or 19.7%, decrease in net sales was due to a $25.8 million decrease in sales volume and a $1.3 million decrease from lower pricing. The sales volume decrease was primarily driven by continued difficult economic conditions, lower backlog entering the year and normalized seasonality. The decrease in total net sales of $27.1 million across our product lines consisted of $18.8 million for in-ground swimming pools, $5.9 million for pool covers and $2.4 million for pool liners.

Cost of Sales and Gross Margin

Cost of sales was $80.0 million for the fiscal quarter ended March 30, 2024, compared to $104.3 million for the fiscal quarter ended April 1, 2023. The $24.3 million, or 23.3%, decrease in cost of sales was primarily the result of the decrease in fixed cost leverage and sales volume and a $0.4 million decrease in non-cash stock-based compensation expense. Gross margin increased by 3.5%, to 27.7% of net sales for the fiscal quarter ended March 30, 2024, compared to 24.2% of net sales for the fiscal quarter ended April 1, 2023. The 3.5% increase in gross margin was primarily driven by our improved cost structure, increased productivity associated with ongoing lean and value engineering efforts and lower material costs.

Selling, General, and Administrative Expense

Selling, general, and administrative expense was $26.3 million for the fiscal quarter ended March 30, 2024, compared to $33.1 million for the fiscal quarter ended April 1, 2023, and decreased as a percentage of net sales by 0.2%. The $6.8 million, or 20.6%, decrease in selling, general, and administrative expense was primarily driven by a $5.1 million decrease in non-cash stock-based compensation expense, lower headcount and reduced expenses.

26

Amortization

Amortization was $6.4 million for the fiscal quarter ended March 30, 2024, compared to $6.6 million for the fiscal quarter ended April 1, 2023. The $0.2 million, or 3.3%, decrease in amortization was driven by certain definite-lived intangible assets becoming fully amortized during the fiscal year ended December 31, 2023.

Interest Expense, net

Interest expense, net was $5.0 million for the fiscal quarter ended March 30, 2024, compared to $10.8 million for the fiscal quarter ended April 1, 2023. The $5.8 million, or 53.9%, decrease in interest expense, net was primarily the result of the change in the fair value of our interest rate swap, compared to the fiscal quarter ended April 1, 2023, partially offset by a higher effective interest rate on lower total borrowings.

Other Expense, Net

Other expense, net was $1.6 million for the fiscal quarter ended March 30, 2024, compared to $0.2 million for fiscal quarter ended April 1, 2023. The $1.4 million increase in other expense was primarily driven by an unfavorable change in net foreign currency transaction gains and losses associated with our international subsidiaries.

Earnings from Equity Method Investment

Earnings from our equity method investment in Premier Pools & Spa were $1.3 million for the fiscal quarter ended March 30, 2024, compared to less than $0.1 million for the fiscal quarter ended April 1, 2023, because of the financial performance of Premier Pools & Spa.

Income Tax Expense (Benefit)

Income tax expense was $0.5 million for the fiscal quarter ended March 30, 2024, compared to income tax benefit of $(2.9) million for the fiscal quarter ended April 1, 2023. Our effective tax rate was (7.2)% for the fiscal quarter ended March 30, 2024, compared to 16.9% for the fiscal quarter ended April 1, 2023. The difference between the U.S. federal statutory income tax rate and our effective income tax rate for both the fiscal quarters ended March 30, 2024 and April 1, 2023 was primarily attributable to the discrete impact of stock-based compensation expense and foreign income.

Net Loss

Net loss was $7.9 million for the fiscal quarter ended March 30, 2024, compared to $14.4 million for the fiscal quarter ended April 1, 2023. The $6.5 million, or 45.3%, decrease in net loss was primarily because of the factors described above.

Net Loss Margin

Net loss margin was 7.1% for the fiscal quarter ended March 30, 2024, compared to 10.4% for the fiscal quarter ended April 1, 2023. The 3.3% decrease in net loss margin was driven by a $6.5 million decrease in net loss, compared to the fiscal quarter ended April 1, 2023 because of the factors described above.

Adjusted EBITDA

Adjusted EBITDA was $12.3 million for the fiscal quarter ended March 30, 2024, compared to $11.0 million for the fiscal quarter ended April 1, 2023. The $1.3 million, or 11.4%, increase in Adjusted EBITDA was primarily because of the increase in gross margin and the reduction in selling, general and administrative expenses, partially offset by the decrease in net sales, as well as the other factors described above.

Adjusted EBITDA Margin

Adjusted EBITDA margin was 11.1% for the fiscal quarter ended March 30, 2024, compared to 8.0% for the fiscal quarter ended April 1, 2023. The 3.1% increase in Adjusted EBITDA margin was primarily because of a $1.3 million increase in Adjusted EBITDA and a $27.1 million decrease in net sales, compared to the fiscal quarter ended April 1, 2023, which were impacted by the factors described above.

27

Non-GAAP Financial Measures

Adjusted EBITDA and Adjusted EBITDA Margin

Adjusted EBITDA and Adjusted EBITDA margin are key metrics used by management and our Board of Directors to assess our financial performance. Adjusted EBITDA and Adjusted EBITDA margin are also frequently used by analysts, investors, and other interested parties to evaluate companies in our industry, when considered alongside other GAAP measures. We use Adjusted EBITDA and Adjusted EBITDA margin to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, to utilize as a significant performance metric in our incentive compensation plans, and to compare our performance against that of other companies using similar measures. We have presented Adjusted EBITDA and Adjusted EBITDA margin solely as supplemental disclosures because we believe they allow for a more complete analysis of results of operations and assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance, such as (i) depreciation and amortization, (ii) interest expense, (iii) income tax (benefit) expense, (iv) loss (gain) on sale and disposal of property and equipment, (v) restructuring charges, (vi) stock-based compensation expense, (vii) unrealized (gains) losses on foreign currency transactions, (viii) strategic initiative costs, (ix) acquisition and integration related costs, (x) the Odessa fire and other such unusual events and (xi) other.

Adjusted EBITDA and Adjusted EBITDA margin are non-GAAP financial measures and should not be considered as alternatives to net income (loss) as a measure of financial performance or any other performance measure derived in accordance with GAAP, and they should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA and Adjusted EBITDA margin, you should be aware that in the future we may incur expenses that are the same as or similar to some of the adjustments in this presentation. There can be no assurance that we will not modify the presentation of Adjusted EBITDA and Adjusted EBITDA margin in the future, and any such modification may be material. Our presentation of Adjusted EBITDA and Adjusted EBITDA margin should not be construed to imply that our future results will be unaffected by any such adjustments. In addition, other companies, including companies in our industry, may not calculate Adjusted EBITDA and Adjusted EBITDA margin at all or may calculate Adjusted EBITDA and Adjusted EBITDA margin differently and accordingly, are not necessarily comparable to similarly entitled measures of other companies, which reduces the usefulness of Adjusted EBITDA and Adjusted EBITDA margin as tools for comparison.

Adjusted EBITDA and Adjusted EBITDA margin have their limitations as analytical tools, and you should not consider them in isolation or as a substitute for analysis of our results as reported under GAAP. Some of these limitations are that Adjusted EBITDA and Adjusted EBITDA margin:

do not reflect every expenditure, future requirements for capital expenditures or contractual commitments;
do not reflect changes in our working capital needs;
do not reflect the interest expense, or the amounts necessary to service interest or principal payments, on our outstanding debt;
do not reflect income tax (benefit) expense, and because the payment of taxes is part of our operations, tax expense is a necessary element of our costs and ability to operate;
do not reflect non-cash stock-based compensation, which will remain a key element of our overall compensation package; and
do not reflect the impact of earnings or charges resulting from matters we consider not to be indicative of our ongoing operations.

Although depreciation and amortization are eliminated in the calculation of Adjusted EBITDA and Adjusted EBITDA margin, the assets being depreciated and amortized will often have to be replaced in the future, and Adjusted EBITDA and Adjusted EBITDA margin do not reflect any costs of such replacements.

Management compensates for these limitations by primarily relying on our GAAP results, while using Adjusted EBITDA and Adjusted EBITDA margin as supplements to the corresponding GAAP financial measures.

28

The following table provides a reconciliation of our net loss to Adjusted EBITDA for the periods presented and the calculation of Adjusted EBITDA margin:

Fiscal Quarter Ended

March 30, 2024

    

April 1, 2023

   

(dollars in thousands)

Net loss

$

(7,864)

$

(14,368)

Depreciation and amortization

10,375

9,258

Interest expense, net

4,982

10,804

Income tax expense (benefit)

532

(2,928)

Loss on sale and disposal of property and equipment

12

8

Restructuring charges(a)

318

519

Stock-based compensation expense(b)

1,243

6,769

Unrealized losses on foreign currency transactions(c)

1,584

730

Strategic initiative costs(d)

1,123

1,067

Acquisition and integration related costs(e)

11

Odessa fire(f)

(864)

Other(g)

(12)

27

Adjusted EBITDA

$

12,293

$

11,033

Net sales

$

110,629

$

137,719

Net loss margin

 

(7.1)

%  

 

(10.4)

%  

Adjusted EBITDA margin

 

11.1

%  

 

8.0

%  

(a)Represents costs related to a cost reduction plan that includes severance and other costs for our executive management changes and additional costs related to our cost reduction plans, which include further actions to reduce our manufacturing overhead by reducing headcount in addition to facility shutdowns.
(b)Represents non-cash stock-based compensation expense.
(c)Represents unrealized foreign currency transaction losses associated with our international subsidiaries.
(d)Represents fees paid to external consultants and other expenses for our strategic initiatives.
(e)Represents acquisition and integration costs as well as other costs related to potential transactions.
(f)Represents costs incurred and insurance recoveries related to a production facility fire in Odessa, Texas.
(g)Other costs consist of other discrete items as determined by management, primarily including: (i) fees paid to external advisors for various matters and (ii) other items.

29

Liquidity and Capital Resources

Overview

Our primary sources of liquidity are net cash provided by operating activities and availability under our Revolving Credit Facility (as defined below). Historically, we have funded working capital requirements, capital expenditures, payments related to acquisitions, and debt service requirements with internally generated cash on hand, borrowings under our credit facilities, and the issuance of shares of our common stock. Our primary cash needs are to fund working capital, capital expenditures, debt service requirements, any acquisitions or investments we may undertake, and any share repurchases we may make. As of March 30, 2024, we had $43.8 million of cash, $282.8 million of outstanding indebtedness and an additional $75.0 million of borrowing availability under our Revolving Credit Facility.

Our primary working capital requirements are for the purchase of inventory, payroll, rent, facility costs and other selling, general, and administrative costs. Our working capital requirements fluctuate during the fiscal year, driven primarily by seasonality and the timing of raw material purchases. Our capital expenditures are primarily related to investments in lean manufacturing and value engineering, including production capacity, diversifying our product offerings, storage, and delivery equipment. We are in the midst of a multi-year capital plan to invest in our facilities, technology, and systems.

We believe that our existing cash, cash generated from operations and availability under our Revolving Credit Facility will be adequate to fund our operating expenses and capital expenditure requirements over the next 12 months, as well as our longer-term liquidity needs. We have based this estimate on assumptions that may prove to be wrong, and we could utilize our available capital resources sooner than we expect. We may issue debt or equity securities, which may provide an additional source of liquidity. However, there can be no assurance equity or debt financing will be available to us when we need it or, if available, the terms will be satisfactory to us and not dilutive to our then-current stockholders.

Our Indebtedness

On February 23, 2022, Latham Pool Products, Inc. (“Latham Pool Products”), our wholly owned subsidiary, entered into an agreement (the “Credit Agreement”) with Barclays Bank PLC, which provides a senior secured multicurrency revolving line of credit in an initial principal amount of $75.0 million (the “Revolving Credit Facility”) and a U.S. Dollar senior secured term loan (the “Term Loan”) in an initial principal amount of $325.0 million (the “Refinancing”). On such date, proceeds under the Credit Agreement were used to repay and replace $294.0 million under, and terminate, the previous credit agreement and for general corporate purposes.

As of March 30, 2024, we were in compliance with all covenants under the Revolving Credit Facility and the Term Loan.

Revolving Credit Facility

The Revolving Credit Facility may be utilized to finance ongoing general corporate and working capital needs and permits Latham Pools Products to borrow loans in U.S. Dollars, Canadian Dollars, Euros and Australian Dollars. The Revolving Credit Facility matures on February 23, 2027. Loans outstanding under the Revolving Credit Facility denominated in U.S. Dollars and Canadian Dollars bear interest, at the borrower’s option, at a rate per annum based on Term SOFR or CDO (each, as defined in the Credit Agreement), as applicable, plus a margin of 3.50%, or at a rate per annum based on the Base Rate or the Canadian Prime Rate (each, as defined in the Credit Agreement), plus a margin of 2.50%. Loans outstanding under the Revolving Credit Facility denominated in Euros or Australian Dollars bear interest based on EURIBOR or the AUD Rate (each, as defined in the Credit Agreement), respectively, plus a margin of 3.50%. A commitment fee accrues on any unused portion of the commitments under the Revolving Credit Facility. The commitment fee is due and payable quarterly in arrears, and initially was 0.375% per annum and thereafter accrues at a rate per annum ranging from 0.25% to 0.50%, depending on the First Lien Net Leverage Ratio (as defined in the Credit Agreement, the “First Lien Net Leverage Ratio”). The Revolving Credit Facility is not subject to amortization.

We are also required to meet certain financial covenants, including maintaining specific liquidity measurements. There are also negative covenants, including certain restrictions on our ability and the ability of our subsidiaries to incur additional indebtedness, create liens, make investments, consolidate, or merge with other entities, enter into transactions with affiliates, make prepayments with respect to certain indebtedness, make dividend payments, loans, or advances to the Company, declare dividends and make restricted payments and other distributions.

As of March 30, 2024, we had no outstanding borrowings under the Revolving Credit Facility and $75.0 million was available for future borrowing.

30

Term Loan

The Term Loan matures on February 23, 2029. Loans outstanding under the Term Loan bear interest, at the borrower’s option, at a rate per annum based on Term SOFR (as defined in the Credit Agreement), plus a margin ranging from 3.75% to 4.00%, depending on the First Lien Net Leverage Ratio, or based on the Base Rate (as defined in the Credit Agreement), plus a margin ranging from 2.75% to 3.00%, depending on the First Lien Net Leverage Ratio. Loans under the Term Loan are subject to scheduled quarterly amortization payments equal to 0.25% of the initial principal amount of the Term Loan.

The obligations under the Credit Agreement are guaranteed by certain of our wholly owned subsidiaries as defined in the security agreement. The obligations under the Credit Agreement are secured by substantially all of the guarantors’ tangible and intangible assets, including, but not limited to, their accounts receivables, equipment, intellectual property, inventory, cash and cash equivalents, deposit accounts and security accounts. The Credit Agreement also restricts payments and other distributions unless certain conditions are met, which could restrict our ability to pay dividends.

As of March 30, 2024, we had $282.8 million of outstanding borrowings under the Term Loan.

Share Repurchase Program

On May 10, 2022, our Board of Directors approved a stock repurchase program (the “Repurchase Program”), which authorizes us to repurchase up to $100 million of our shares of common stock by May 2025. We may effect these repurchases in open market transactions, privately negotiated purchases or other acquisitions. We are not obligated to repurchase any of our outstanding shares under the Repurchase Program and the timing and amount of any repurchases will depend on market conditions, our stock price, alternative uses of capital, the terms of our debt instruments and other factors. We did not repurchase any shares of our common stock during the fiscal quarter ended March 30, 2024. As of March 30, 2024, $77.0 million remained available for share repurchases pursuant to our Repurchase Program.

Cash Flows

The following table summarizes our sources and uses of cash for each of the periods presented:

Fiscal Quarter Ended

March 30, 2024

    

April 1, 2023

(in thousands)

Net cash used in operating activities

$

(34,512)

$

(14,476)

Net cash used in investing activities

 

(5,345)

 

(9,942)

Net cash (used in) provided by financing activities

 

(19,002)

 

47,086

Effect of exchange rate changes on cash

 

(93)

 

(278)

Net (decrease) increase in cash

$

(58,952)

$

22,390

Operating Activities

During the fiscal quarter ended March 30, 2024, operating activities used $34.5 million of cash. Net loss, after adjustments for non-cash items, provided cash of $6.8 million. Cash used in operating activities was driven by changes in our operating assets and liabilities of $41.3 million. Net cash used by changes in our operating assets and liabilities for the fiscal quarter ended March 30, 2024 consisted primarily of a $44.9 million increase in trade receivables, a $6.0 million decrease in accrued expenses and other current liabilities, a $0.4 million increase in income tax receivable, a $0.2 million decrease in other long-term liabilities and a $0.1 million increase in other assets, partially offset by a $8.2 million increase in accounts payable, a $1.6 million decrease in inventories and a $0.5 million decrease in prepaid expenses and other current assets. The change in trade receivables was primarily driven by the timing of net sales. The changes in accrued expenses and other current liabilities and accounts payable were primarily driven by volume of purchases and timing of payments.

During the fiscal quarter ended April 1, 2023, operating activities used $14.5 million of cash. Net loss, after adjustments for non-cash items, provided cash of $11.4 million. Cash used in operating activities was driven by changes in our operating assets and liabilities of $25.8 million. Net cash used by changes in our operating assets and liabilities for the fiscal quarter ended April 1, 2023 consisted primarily of a $55.3 million increase in trade receivables, a $2.8 million increase in income tax receivable, a $1.2 million increase in other assets, a $0.6 million increase in prepaid expenses and other current assets, and a $3.2 million decrease in accrued expenses and other current liabilities, partially offset by a $15.6 million decrease in inventories, a $20.9 million increase in accounts

31

payable, and a $0.7 million increase in other long-term liabilities. The change in trade receivables was primarily driven by the timing of net sales, and the decrease in inventories was primarily driven by efforts to meet demand outlook while maintaining lead times and service levels. The changes in accrued expenses and other current liabilities and accounts payable were primarily driven by volume of purchases and timing of payments.

Investing Activities

During the fiscal quarter ended March 30, 2024, investing activities used $5.3 million of cash, consisting of purchases of property and equipment for $5.3 million. The purchase of property and equipment was primarily to expand capacity for production and diversify offerings, especially for fiberglass pools, the majority of which relates to finishing up carryover projects from the prior year.

During the fiscal quarter ended April 1, 2023, investing activities used $9.9 million of cash, consisting of purchases of property and equipment for $9.9 million. The purchase of property and equipment was primarily to expand capacity for production, especially for fiberglass pools.

Financing Activities

During the fiscal quarter ended March 30, 2024, financing activities used $19.0 million of cash, primarily consisting of repayments on long-term debt borrowings of $18.8 million and repayments of finance lease obligations of $0.2 million.

During the fiscal quarter ended April 1, 2023, financing activities provided $47.1 million of cash, primarily consisting of borrowings on revolving credit facility of $48.0 million, partially offset by repayments on long-term debt borrowings of $0.8 million, and repayments of finance lease obligations of $0.1 million.

Contractual Obligations

There have been no material changes, outside of the ordinary course of business, to our contractual obligations during the fiscal quarter ended March 30, 2024 from those described under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Contractual Obligations” in our Annual Report.

Critical Accounting Policies and Estimates

Our condensed consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. Throughout the preparation of these financial statements, we have made estimates and assumptions that impact the reported amounts of assets, liabilities, and the disclosure of contingent liabilities at the date of the financial statements and revenues and expenses during the reporting period. Our critical accounting policies and estimates are described below and under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Critical Accounting Policies and Estimates” in our Annual Report and Note 2 to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q. These estimates are based on historical results, trends, and other assumptions we believe to be reasonable. We evaluate these estimates on an ongoing basis. Actual results may differ from estimates.

Impairment of Goodwill

We evaluate goodwill for impairment at least annually, or more frequently when events or changes in circumstances indicate that the carrying value may not be recoverable. We have selected the first day of the fourth fiscal quarter to perform our annual goodwill impairment testing.

We may assess our goodwill for impairment initially using a qualitative approach, or step zero, to determine whether conditions exist to indicate that it is more likely than not that the fair value of the reporting unit is less than its carrying value. The qualitative assessment requires significant judgments by management about economic conditions including the entity’s operating environment, its industry and other market considerations, entity-specific events related to financial performance or loss of key personnel, and other events that could impact the reporting unit. If management concludes, based on assessment of relevant events, facts, and circumstances, that it is more likely than not that the reporting unit’s fair value is greater than its carrying value, no further impairment testing is required.

If our assessment of qualitative factors indicates that it is more likely than not that the fair value of the reporting unit is less than its carrying value, then a quantitative assessment is performed. We may also elect to initially perform a quantitative analysis instead of

32

starting with step zero. The quantitative analysis requires comparing the carrying value of the reporting unit, including goodwill, to its fair value. If the fair value of the reporting unit exceeds its carrying amount, goodwill is not considered to be impaired and no further testing is required. If the carrying amount of the reporting unit exceeds its fair value, there is an impairment of goodwill and an impairment loss is recorded. We calculate the impairment loss by comparing the fair value of the reporting unit less the carrying value, including goodwill. The maximum goodwill impairment is the carrying value of the goodwill.

The qualitative factors we assessed as part of our annual impairment testing included economic conditions, industry and market considerations, cost factors, overall financial performance, and other entity specific events. In addition, we considered our market capitalization based on quoted market prices of our securities on the Nasdaq Global Select Market, adjusted for the effect of a control premium as contemplated by ASC 350.

Based on the results of the quantitative assessment performed for our one reporting unit, we determined that goodwill was not impaired at October 1, 2023. However, if factors exist that could indicate an impairment in the future, including a sustained decrease in our stock price, we may be required to record impairment charges in future periods.

Recently Issued and Adopted Accounting Pronouncements

A description of recently issued accounting pronouncements that may potentially impact our financial position, results of operations or cash flows is disclosed in Note 2 to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures about Market Risk

Market risk is the potential loss that may result from market changes associated with our business or with an existing or forecasted financial transaction. The value of a financial instrument may change as a result of changes in interest rates, exchange rates, commodity prices, equity prices and other market changes. We are exposed to changes in interest rates and foreign currency exchange rates because we finance certain operations through variable rate debt instruments and denominate some of our transactions in foreign currencies. Changes in these rates may have an impact on future cash flow and earnings. We manage these risks through normal operating and financing activities.

During the fiscal quarter ended March 30, 2024, there have been no material changes to the information included under the heading “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Quantitative and Qualitative Disclosures about Market Risk” in our Annual Report.

Interest Rate Risk

We entered into an additional interest rate swap that was executed on March 10, 2023. The swap has an effective date of May 18, 2023 and a termination date of May 18, 2026. Under the terms of the swap, we fixed our SOFR borrowing rate on a notional amount of $161.0 million. The interest rate swap is not designated as a hedging instrument for accounting purposes.

An increase or decrease of 1% in the effective interest rate, giving effect related to interest rate swaps, as of March 30, 2024, would cause an increase or decrease to annual interest expense, net of approximately $1.3 million.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

As required by Rules 13a-15 and 15d-15 under the Exchange Act, our Chief Executive Officer and Chief Financial Officer carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of March 30, 2024.

33

Based upon their evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of March 30, 2024.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) during the most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Controls and Procedures

In designing and evaluating the disclosure controls and procedures and internal control over financial reporting, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of a control system must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements related to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.

PART II — OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we are involved in litigation relating to claims arising out of our operations and businesses, including, among others, contract and employment claims, personal injury claims, intellectual property claims, product liability claims and warranty claims. Currently, there are no claims or proceedings against us that we believe will have a material adverse effect on our business, financial condition, results of operations or cash flows. Further, no material legal proceedings were terminated, settled, or otherwise resolved during the fiscal quarter ended March 30, 2024. However, the results of any current or future litigation cannot be predicted with certainty and, regardless of the outcome, we may incur significant costs and experience a diversion of management resources as a result of litigation.

Item 1A. Risk Factors

We have disclosed under the heading “Risk Factors” in our Annual Report, the risk factors that materially affect our business, financial condition, and results of operations. There have been no material changes from the risk factors previously disclosed in our Annual Report. You should carefully consider the risks, uncertainties, assumptions and other important factors set forth in the Annual Report and other subsequent reports we file or furnish with the SEC, including this Quarterly Report on Form 10-Q, any of which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied. For similar reasons, our past results may not be a reliable indicator of future performance and trends. You also should be aware that these risk factors and other information do not describe every risk that we face. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may affect us. We operate in a very competitive and rapidly changing environment and new risks emerge from time to time, and we anticipate that subsequent events and developments will cause our views to change. In addition, these risks do not reflect the potential impact of any future acquisitions, merger, dispositions, joint ventures or investments we may undertake. Any of these known or emerging factors may materially adversely affect our business, financial condition, and operating results, as well as the trading price of our common stock.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On May 10, 2022, our Board of Directors approved a stock repurchase program, which authorizes us to repurchase up to $100.0 million of our shares of common stock by May 2025. We may effect these repurchases in open market transactions, privately negotiated purchases or other acquisitions. We are not obligated to repurchase any of our shares of our common stock under the program and the timing and amount of any repurchases will depend on market conditions, our stock price, alternative uses of capital, the terms of our debt instruments and other factors. As of March 30, 2024, $77.0 million remained available for share repurchases pursuant to the repurchase program. We did not repurchase any shares of our common stock during the fiscal quarter ended March 30, 2024.

34

Item 5. Other Information

Rule 10b5-1 Trading Plans – Directors and Section 16 Officers

During the fiscal quarter ended March 30, 2024, none of the Company's directors or Section 16 officers adopted or terminated (i) any contract, instruction or written plan for the purchase or sale of Company securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act or (ii) any "non-Rule 10b5-1 trading arrangement."

35

Item 6. Exhibits

Exhibit
No.

    

Description

3.1

Amended and Restated Certificate of Incorporation of Latham Group, Inc. (incorporated by reference to Exhibit 3.1 to Latham Group, Inc.’s Quarterly Report on Form 10-Q filed with the SEC on June 3, 2021 (File No. 001-40358))

3.2

Amended and Restated Bylaws of Latham Group, Inc. (incorporated by reference to Exhibit 3.2 to Latham Group, Inc.’s Quarterly Report on Form 10-Q filed with the SEC on June 3, 2021 (File No. 001-40358))

10.1†

Form of Performance Stock Unit Award Agreement under the 2021 Omnibus Equity Incentive Plan (incorporated by reference to Exhibit 10.20 to Latham Group, Inc.’s Annual Report on Form 10-K filed with the SEC on March 13, 2024 (File No. 001-40358))

10.2*†

Latham Group, Inc. Amended and Restated Non-Employee Director Compensation Policy

31.1*

Certification of CEO, pursuant to SEC Rule 13a-14(a) and 15d-14(a)

31.2*

Certification of CFO, pursuant to SEC Rule 13a-14(a) and 15d-14(a)

32.1**

Certification by the CEO, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2**

Certification by the CFO, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS**

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document

101.SCH**

Inline XBRL Taxonomy Extension Schema Document

101.CAL**

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF**

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB**

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE**

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104**

Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

Indicates management contract or compensatory plan.

*

Filed herewith.

**

Furnished herewith.

36

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date       May 8, 2024

LATHAM GROUP, INC.

/s/ Oliver C. Gloe

Oliver C. Gloe

Chief Financial Officer

(Principal Financial Officer)

37

Exhibit 10.2

Graphic

Amended and Restated

Non-Employee Director Compensation Policy

(Effective March 4, 2024)

Each “non-employee director” of Latham Group, Inc. (the “Company”) will be entitled to receive the following compensation (directors that are (i) employees of the Company or any of its subsidiaries or (ii) directors that are employed by or affiliated with our Sponsors (Pamplona Capital Management, LLC and Wynnchurch Capital, L.P.) shall not be entitled to the compensation listed below or any additional compensation in respect of their service as a member of the Company’s board of directors (the “Board”)):

1.Annual Cash Retainer: $75,000; to be paid in quarterly installments.

2.

Annual Equity Grant: $95,000. The number of shares granted will be equal to $95,000 divided by the fair market value of the underlying stock on the date of grant. The Annual Equity Grant will be shares of restricted stock or restricted stock units and such shares will vest and the restrictions will lapse on the first anniversary of the date of grant, unless the director is removed for cause or resigns prior to such date.

3.Chairman of the Board: (COB):

a.Annual COB Cash Retainer $50,000; to be paid in quarterly instalments.

b.Annual COB Equity Grant $30,000. The number of shares granted will be equal to $30,000 divided by the fair market value of the underlying stock on the date of grant. The Annual COB Equity Grant will be shares of restricted stock or restricted stock units and such shares will vest and the restrictions will lapse on the first anniversary of the date of grant, unless the COB is removed for cause or resigns prior to such date.

4.

Audit Committee: Retainer for Chairperson of the Audit Committee: $20,000; paid in quarterly installments.

5.

Compensation Committee: Retainer for the Chairperson of the Compensation Committee: $15,000; paid in quarterly installments.

6.

Nominating and Corporate Governance Committee: Retainer for the Chairperson of the Nominating and Corporate Governance Committee: $10,000; paid in quarterly installments.

7.

Payments: All payments which are made in installments are subject to the director’s continued service on the Board on the date such installment is required to be paid.

8.

Amendment; Modification; Termination & Administration. This policy is to be administered by the Company’s Compensation Committee or their designee, unless the Board determines to administer this policy itself (the Committee or Board, as applicable, in its role administering this policy, the “Administrator”). The Administrator is permitted to amend or modify the policy in its discretion.


Exhibit 31.1

LATHAM GROUP, INC.

I, Scott M. Rajeski, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Latham Group, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Securities Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Securities Exchange Act Rule 13-a15(f) and 15d-15(f)) for the registrant and have:

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 8, 2024

/s/ Scott M. Rajeski

 

Scott M. Rajeski

 

Chief Executive Officer and President

 

Latham Group, Inc.


Exhibit 31.2

LATHAM GROUP, INC.

I, Oliver C. Gloe, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Latham Group, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Securities Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Securities Exchange Act Rule 13-a15(f) and 15d-15(f)) for the registrant and have:

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c.

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.

The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

May 8, 2024

/s/ Oliver C. Gloe

 

Oliver C. Gloe

 

Chief Financial Officer

 

Latham Group, Inc.


Exhibit 32.1

LATHAM GROUP, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Latham Group, Inc. (the “Company”) on Form 10-Q for the period ending March 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Scott M. Rajeski, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 8, 2024

/s/ Scott M. Rajeski

 

Scott M. Rajeski

 

Chief Executive Officer and President

 

Latham Group, Inc.

The foregoing certification is being furnished as an exhibit to the Report pursuant to Item 601(b)(32) of Regulation S-K and Section 1350 of Title 18 of the United States Code and, accordingly, is not being filed with the U.S. Securities and Exchange Commission as part of the Report and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Report, irrespective of any general incorporation language contained in such filing).


Exhibit 32.2

LATHAM GROUP, INC.

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Latham Group, Inc. (the “Company”) on Form 10-Q for the period ending March 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Oliver C. Gloe, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

May 8, 2024

/s/ Oliver C. Gloe

 

Oliver C. Gloe

 

Chief Financial Officer

 

Latham Group, Inc.

The foregoing certification is being furnished as an exhibit to the Report pursuant to Item 601(b)(32) of Regulation S-K and Section 1350 of Title 18 of the United States Code and, accordingly, is not being filed with the U.S. Securities and Exchange Commission as part of the Report and is not to be incorporated by reference into any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934 (whether made before or after the date of the Report, irrespective of any general incorporation language contained in such filing).


v3.24.1.u1
Document and Entity Information - shares
3 Months Ended
Mar. 30, 2024
May 03, 2024
Document and Entity Information [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Transition Report false  
Document Period End Date Mar. 30, 2024  
Entity File Number 001-40358  
Entity Registrant Name Latham Group, Inc.  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 83-2797583  
Entity Address State Or Province NY  
Entity Address, Address Line One 787 Watervliet Shaker Road  
Entity Address, City or Town Latham  
Entity Address, Postal Zip Code 12110  
City Area Code 800  
Local Phone Number 833-3800  
Title of 12(b) Security Common stock, par value $0.0001 per share  
Trading Symbol SWIM  
Security Exchange Name NASDAQ  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   115,572,774
Entity Central Index Key 0001833197  
Current Fiscal Year End Date --12-31  
Document Fiscal Year Focus 2024  
Document Fiscal Period Focus Q1  
Amendment Flag false  
v3.24.1.u1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 30, 2024
Dec. 31, 2023
Current assets:    
Cash $ 43,811 $ 102,763
Trade receivables, net 73,944 30,407
Inventories, net 95,151 97,137
Income tax receivable 1,411 983
Prepaid expenses and other current assets 6,996 7,327
Total current assets 221,313 238,617
Property and equipment, net 112,795 113,014
Equity method investment 26,341 25,940
Deferred tax assets 7,310 7,485
Operating lease right-of-use assets 28,696 30,788
Goodwill 130,987 131,363
Intangible assets, net 275,876 282,793
Other assets 5,294 5,003
Total assets 808,612 835,003
Current liabilities:    
Current maturities of long-term debt 3,250 21,250
Current operating lease liabilities 6,823 7,133
Accrued expenses and other current liabilities 35,781 40,691
Total current liabilities 70,876 86,206
Long-term debt, net of discount, debt issuance costs, and current portion 279,531 279,951
Deferred income tax liabilities, net 40,088 40,088
Non-current operating lease liabilities 22,963 24,787
Other long-term liabilities 3,386 4,771
Total liabilities 416,844 435,803
Commitments and contingencies
Stockholders' equity:    
Preferred stock, $0.0001 par value; 100,000,000 shares authorized as of both March 30, 2024 and December 31, 2023; no shares issued and outstanding as of both March 30, 2024 and December 31, 2023
Common stock, $0.0001 par value; 900,000,000 shares authorized as of March 30, 2024 and December 31, 2023; 115,389,689 and 114,871,782 shares issued and outstanding, as of March 30, 2024 and December 31, 2023, respectively 11 11
Additional paid-in capital 460,927 459,684
Accumulated deficit (64,820) (56,956)
Accumulated other comprehensive loss (4,350) (3,539)
Total stockholders' equity 391,768 399,200
Total liabilities and stockholders' equity 808,612 835,003
Related Party    
Current liabilities:    
Accounts payable   8
Nonrelated Party    
Current liabilities:    
Accounts payable $ 25,022 $ 17,124
v3.24.1.u1
Consolidated Balance Sheets (Parenthetical) - $ / shares
Mar. 30, 2024
Dec. 31, 2023
Consolidated Balance Sheets    
Preferred stock, par value $ 0.0001 $ 0.0001
Preferred stock, shares authorized 100,000,000 100,000,000
Preferred stock, shares issued 0 0
Preferred stock, shares outstanding 0 0
Common stock, par value $ 0.0001 $ 0.0001
Common stock, shares authorized 900,000,000 900,000,000
Common stock, shares issued 115,389,689 114,871,782
Common stock, shares outstanding 115,389,689 114,871,782
v3.24.1.u1
Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Consolidated Statements of Operations    
Net sales $ 110,629 $ 137,719
Cost of sales 80,040 104,349
Gross profit 30,589 33,370
Selling, general, and administrative expense 26,250 33,057
Amortization 6,412 6,632
Loss from operations (2,073) (6,319)
Other expense:    
Interest expense, net 4,982 10,804
Other expense, net 1,586 210
Total other expense, net 6,568 11,014
Earnings from equity method investment 1,309 37
Loss before income taxes (7,332) (17,296)
Income tax expense (benefit) 532 (2,928)
Net loss $ (7,864) $ (14,368)
Net loss per share attributable to common stockholders:    
Basic $ (0.07) $ (0.13)
Diluted $ (0.07) $ (0.13)
Weighted-average common shares outstanding - basic and diluted    
Basic 115,038,929 112,102,198
Diluted 115,038,929 112,102,198
v3.24.1.u1
Consolidated Statements of Comprehensive Loss - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Consolidated Statements of Comprehensive Loss    
Net loss $ (7,864) $ (14,368)
Other comprehensive loss, net of tax:    
Foreign currency translation adjustments (811) (144)
Total other comprehensive loss, net of tax (811) (144)
Comprehensive loss $ (8,675) $ (14,512)
v3.24.1.u1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
(Accumulated Deficit) Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Total
Balance, beginning of period at Dec. 31, 2022 $ 11 $ 440,880 $ (54,568) $ (3,533) $ 382,790
Balance, beginning of period (in shares) at Dec. 31, 2022 114,667,975        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss     (14,368)   (14,368)
Foreign currency translation adjustments       (144) (144)
Issuance of common stock upon release of restricted stock units (in shares) 22,078        
Stock-based compensation expense   6,769     6,769
Balance, end of period at Apr. 01, 2023 $ 11 447,649 (68,936) (3,677) 375,047
Balance, end of period (in shares) at Apr. 01, 2023 114,690,053        
Balance, beginning of period at Dec. 31, 2023 $ 11 459,684 (56,956) (3,539) 399,200
Balance, beginning of period (in shares) at Dec. 31, 2023 114,871,782        
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net loss     (7,864)   (7,864)
Foreign currency translation adjustments       (811) (811)
Issuance of common stock upon release of restricted stock units (in shares) 517,907        
Stock-based compensation expense   1,243     1,243
Balance, end of period at Mar. 30, 2024 $ 11 $ 460,927 $ (64,820) $ (4,350) $ 391,768
Balance, end of period (in shares) at Mar. 30, 2024 115,389,689        
v3.24.1.u1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Cash flows from operating activities:    
Net loss $ (7,864) $ (14,368)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 10,374 9,258
Amortization of deferred financing costs and debt discount 430 430
Non-cash lease expense 1,780 1,877
Change in fair value of interest rate swaps (1,804) 4,866
Stock-based compensation expense 1,243 6,769
Bad debt expense 1,299 1,700
Other non-cash, net 1,757 860
Earnings from equity method investment (1,309) (37)
Distributions received from equity method investment 908  
Changes in operating assets and liabilities:    
Trade receivables (44,895) (55,286)
Inventories 1,648 15,615
Prepaid expenses and other current assets 467 (593)
Income tax receivable (428) (2,816)
Other assets (146) (1,225)
Accounts payable 8,179 20,947
Accrued expenses and other current liabilities (5,987) (3,190)
Other long-term liabilities (164) 717
Net cash used in operating activities (34,512) (14,476)
Cash flows from investing activities:    
Purchases of property and equipment (5,345) (9,942)
Net cash used in investing activities (5,345) (9,942)
Cash flows from financing activities:    
Payments on long-term debt borrowings (18,813) (813)
Proceeds from borrowings on revolving credit facility   48,000
Repayments of finance lease obligations (189) (101)
Net cash (used in) provided by financing activities (19,002) 47,086
Effect of exchange rate changes on cash (93) (278)
Net (decrease) increase in cash (58,952) 22,390
Cash at beginning of period 102,763 32,626
Cash at end of period 43,811 55,016
Supplemental cash flow information:    
Cash paid for interest 9,513 5,123
Income taxes paid, net 39 637
Supplemental disclosure of non-cash investing and financing activities:    
Purchases of property and equipment included in accounts payable and accrued expenses 426 5,849
Capitalized internal-use software included in accounts payable - related party   359
Right-of-use operating and finance lease assets obtained in exchange for lease liabilities $ 198 $ 1,625
v3.24.1.u1
NATURE OF THE BUSINESS
3 Months Ended
Mar. 30, 2024
NATURE OF THE BUSINESS  
NATURE OF THE BUSINESS

1. NATURE OF THE BUSINESS

Latham Group, Inc. (the “Company”) wholly owns Latham Pool Products, Inc. (“Latham Pool Products”) (together, “Latham”), a designer, manufacturer, and marketer of in-ground residential swimming pools in North America, Australia, and New Zealand. Latham offers a portfolio of in-ground swimming pools and related products, including pool liners and pool covers.

Stock Split, Initial Public Offering and Reorganization

On April 13, 2021, the Company’s certificate of incorporation was amended and restated. On April 13, 2021, the Company effected a 109,673.709-for-one stock split of its issued and outstanding shares of common stock. Accordingly, all share and per share data included in these condensed consolidated financial statements and notes thereto have been adjusted retroactively to reflect the impact of the amended and restated certificate of incorporation and the stock split.

On April 27, 2021, the Company completed its initial public offering (the “IPO”), pursuant to which it issued and sold 23,000,000 shares of common stock, inclusive of 3,000,000 shares sold by the Company pursuant to the full exercise of the underwriters’ option to purchase additional shares. The aggregate net proceeds received by the Company from the IPO were $399.3 million, after deducting underwriting discounts and commissions and other offering costs.

Prior to the closing of the Company’s IPO, the Company’s parent entity, Latham Investment Holdings, L.P., merged with and into Latham Group, Inc.

v3.24.1.u1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
3 Months Ended
Mar. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). The Company’s unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Unaudited Interim Financial Information

The unaudited condensed consolidated balance sheet at December 31, 2023 was derived from audited financial statements but does not include all disclosures required by GAAP. The accompanying unaudited condensed consolidated financial statements as of March 30, 2024 and for the fiscal quarters ended March 30, 2024 and April 1, 2023, respectively, have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with Latham Group, Inc.’s audited consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2023 included in the Company’s 2023 Annual Report on Form 10-K, filed with the SEC on March 13, 2024 (the “Annual Report”). In the opinion of management, all adjustments, consisting only of normal recurring adjustments necessary for a fair statement of these condensed consolidated financial statements, have been included. The Company’s results of operations for the fiscal quarter ended March 30, 2024 are not necessarily indicative of the results of operations that may be expected for the fiscal year ending December 31, 2024 or other interim periods thereof.

Use of Estimates

The preparation of the Company’s condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The Company bases its estimates on historical experience, known trends, and other market-specific relevant factors that it believes to be reasonable under the circumstances. Estimates are evaluated on an ongoing basis and revised as there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known.

Reclassifications

Certain prior period balances have been reclassified to conform to the current period presentation in the condensed consolidated financial statements and the accompanying notes.

Seasonality

Although the Company generally has demand for its products throughout the fiscal year, its business is seasonal and weather is one of the principal external factors affecting the business. Historically, net sales and net income are highest (or net loss is lowest) during the second and third fiscal quarters, representing the peak months of swimming pool use, pool installation, and remodeling and repair activities. Severe weather may also affect net sales in all periods.

Significant Accounting Policies

Refer to the Annual Report for a discussion of the Company’s significant accounting policies, as updated below.

Recently Issued Accounting Pronouncements

The Company qualifies as “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 and has elected to “opt in” to the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company will adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and will do so until such time that the Company either (i) irrevocably elects to “opt out” of such extended transition period or (ii) no longer qualifies as an emerging growth company. The Company may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for private companies.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which improves financial reporting by requiring disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful analysis. For all entities, ASU 2023-07 is effective for fiscal years beginning after December 15, 2023. The amendments should be applied retrospectively to all prior periods presented in the financial statements, with early adoption permitted. The Company is currently evaluating ASU 2023-07 and its potential impact on the notes to the condensed consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), in an effort to enhance the transparency and decision usefulness of income tax disclosures. For all entities, ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The amendments should be applied prospectively with retrospective application permitted. Early adoption is also permitted. The Company is currently evaluating ASU 2023-09 and its potential impact on the notes to the condensed consolidated financial statements.

In March 2024, the FASB issued ASU 2024-01, Compensation – Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards (“ASU 2024-01”), which improves financial reporting by providing clarity on when an entity should apply the scope guidance in paragraph 718-10-15-3. For all public entities, ASU 2024-01 is effective for fiscal years beginning after December 15, 2024. The amendments should be applied retrospectively to all prior periods presented in the financial statements, with early adoption permitted. The Company is currently evaluating ASU 2024-01 and its potential impact on the notes to the condensed consolidated financial statements.

v3.24.1.u1
FAIR VALUE MEASUREMENTS
3 Months Ended
Mar. 30, 2024
FAIR VALUE MEASUREMENTS  
FAIR VALUE MEASUREMENTS

3. FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. To increase the comparability of fair value measures, the following hierarchy prioritizes the inputs to valuation methodologies used to measure fair value.

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Inputs, other than quoted prices in active markets, that are observable either directly or indirectly.

Level 3 — Unobservable inputs that reflect the Company’s own assumptions incorporated into valuation techniques. These valuations require significant judgment.

In certain cases, the inputs used to measure fair value may fall into different levels of the fair value hierarchy. When there is more than one input at different levels within the hierarchy, the fair value is determined based on the lowest level input that is significant to the fair value measurement in its entirety. Assessment of the significance of a particular input to the fair value measurement in its entirety requires substantial judgment and consideration of factors specific to the asset or liability. Level 3 inputs are inherently difficult to estimate. Changes to these inputs can have significant impact on fair value measurements. Assets and liabilities measured at fair value using Level 3 inputs are based on one or more of the following valuation techniques: market approach, income approach or cost approach. There were no transfers between fair value measurement levels during the fiscal quarters ended March 30, 2024 and April 1, 2023.

Assets and liabilities measured at fair value on a nonrecurring basis

The Company’s non-financial assets such as goodwill, intangible assets, and property and equipment are measured at fair value upon acquisition and remeasured to fair value when an impairment charge is recognized. Such fair value measurements are based predominantly on Level 2 and Level 3 inputs.

Fair value of financial instruments

The Company considers the carrying amounts of cash, trade receivables, prepaid expenses and other current assets, accounts payable, and accrued expenses and other current liabilities to approximate fair value because of the short-term maturities of these instruments.

Term loan

The Company’s term loan (see Note 6) is carried at amortized cost; however, the Company estimates the fair value of the term loan for disclosure purposes. The fair value of the term loan is determined using inputs based on observable market data of a non-public exchange, which are classified as Level 2 inputs. The following table sets forth the carrying amount and fair value of its term loan (in thousands):

March 30, 2024

December 31, 2023

Carrying

Estimated

Carrying

Estimated

    

Value

    

Fair Value

    

Value

    

Fair Value

Term Loan

$

282,781

$

277,832

$

301,201

$

289,153

Interest rate swap

The Company estimates the fair value of interest rate swaps (see Note 6) on a fiscal quarterly basis using Level 2 inputs, including the forward SOFR curve. The fair value is estimated by comparing (i) the present value of all future monthly fixed rate payments versus (ii) the variable payments based on the forward SOFR curve. As of March 30, 2024 and December 31, 2023, the fair value of the Company’s interest rate swap was an asset of $0.6 million and a liability of $1.2 million, respectively, which were recorded within other assets and other long-term liabilities on the condensed consolidated balance sheets, respectively.

v3.24.1.u1
GOODWILL AND INTANGIBLE ASSETS, NET
3 Months Ended
Mar. 30, 2024
GOODWILL AND INTANGIBLE ASSETS, NET  
GOODWILL AND INTANGIBLE ASSETS, NET

4. GOODWILL AND INTANGIBLE ASSETS, NET

Goodwill

The carrying amount of goodwill as of March 30, 2024 and as of December 31, 2023 was $131.0 million and $131.4 million, respectively. The change in the carrying value during the fiscal quarter ended March 30, 2024 was solely because of fluctuations in foreign currency exchange rates.

Intangible Assets

Intangible assets, net as of March 30, 2024 consisted of the following (in thousands):

March 30, 2024

Gross 

Foreign 

Carrying 

Currency 

Accumulated 

Net 

    

Amount

    

Translation

    

Amortization

    

Amount

Trade names and trademarks

$

148,100

$

(251)

$

31,233

$

116,616

Patented technology

 

16,126

 

(4)

 

9,111

 

7,011

Technology

13,000

2,023

10,977

Pool designs

 

13,628

 

(124)

 

3,207

 

10,297

Franchise relationships

 

1,187

 

 

1,187

 

Dealer relationships

 

197,376

 

(1)

 

66,400

 

130,975

Order backlog

1,600

1,600

Non-competition agreements

 

2,476

 

 

2,476

 

$

393,493

$

(380)

$

117,237

$

275,876

The Company recognized $6.4 million of amortization expense related to intangible assets during the fiscal quarter ended March 30, 2024. The Company recognized $6.6 million of amortization expense related to intangible assets during the fiscal quarter ended April 1, 2023.

Intangible assets, net as of December 31, 2023 consisted of the following (in thousands):

December 31, 2023

Gross 

Foreign 

Carrying 

Currency 

Accumulated 

Net 

    

Amount

    

Translation

    

Amortization

    

Amount

Trade names and trademarks

$

148,100

$

72

$

29,583

$

118,589

Patented technology

 

16,126

 

1

 

8,713

 

7,414

Technology

13,000

1,806

11,194

Pool designs

 

13,628

 

35

 

2,973

 

10,690

Franchise relationships

 

1,187

 

 

1,187

 

Dealer relationships

 

197,376

 

 

62,470

 

134,906

Order backlog

1,600

1,600

Non-competition agreements

 

2,476

 

 

2,476

 

$

393,493

$

108

$

110,808

$

282,793

The Company estimates that amortization expense related to definite-lived intangible assets will be as follows in each of the next five years and thereafter (in thousands):

Estimated Future 

Amortization 

Year Ended

    

Expense

Remainder of fiscal year 2024

$

19,282

2025

 

25,551

2026

 

25,551

2027

 

25,551

2028

 

24,593

Thereafter

 

155,348

$

275,876

v3.24.1.u1
INVENTORIES, NET
3 Months Ended
Mar. 30, 2024
INVENTORIES, NET  
INVENTORIES, NET

5. INVENTORIES, NET

Inventories, net consisted of the following (in thousands):

    

March 30, 2024

    

December 31, 2023

Raw materials

$

53,145

$

55,081

Finished goods

 

42,006

 

42,056

$

95,151

$

97,137

v3.24.1.u1
LONG-TERM DEBT
3 Months Ended
Mar. 30, 2024
LONG-TERM DEBT  
LONG-TERM DEBT

6. LONG-TERM DEBT

The components of the Company’s outstanding long-term debt obligations consisted of the following (in thousands):

    

March 30, 2024

    

December 31, 2023

Term Loan

$

290,500

$

309,313

Revolving Credit Facility

Less: Unamortized discount and debt issuance costs

 

(7,719)

 

(8,112)

Total debt

 

282,781

 

301,201

Less: Current portion of long-term debt

 

(3,250)

 

(21,250)

Total long-term debt

$

279,531

$

279,951

On February 23, 2022, Latham Pool Products entered into an agreement (the “Credit Agreement”) with Barclays Bank PLC, which provides a senior secured multicurrency revolving line of credit (the “Revolving Credit Facility”) in an initial principal amount of $75.0 million and a U.S. Dollar senior secured term loan facility (the “Term Loan”) in an initial principal amount of $325.0 million.

As of March 30, 2024, the Company was in compliance with all financial covenants under the Credit Agreement.

Revolving Credit Facility

The Revolving Credit Facility may be utilized to finance ongoing general corporate and working capital needs and permits Latham Pools Products to borrow loans in U.S. Dollars, Canadian Dollars, Euros and Australian Dollars. The Revolving Credit Facility matures on February 23, 2027. Loans outstanding under the Revolving Credit Facility denominated in U.S. Dollars and Canadian Dollars bear interest, at the borrower’s option, at a rate per annum based on Term SOFR or CDO (each, as defined in the Credit Agreement), as applicable, plus a margin of 3.50%, or at a rate per annum based on the Base Rate or the Canadian Prime Rate (each, as defined in the Credit Agreement), plus a margin of 2.50%. Loans outstanding under the Revolving Credit Facility denominated in Euros or Australian Dollars bear interest based on EURIBOR or the AUD Rate (each, as defined in the Credit Agreement), respectively, plus a margin of 3.50%. A commitment fee accrues on any unused portion of the commitments under the Revolving Credit Facility. The commitment fee is due and payable quarterly in arrears, and initially was 0.375% per annum and thereafter accrues at a rate per annum ranging from 0.25% to 0.50%, depending on the First Lien Net Leverage Ratio (as defined in the Credit Agreement, the “First Lien Net Leverage Ratio”). Borrowings under the Revolving Credit Facility are due at maturity.

The Company incurred debt issuance costs of $0.8 million related to the Revolving Credit Facility. The debt issuance costs were recorded within other assets on the condensed consolidated balance sheet as of the applicable period and are being amortized over the life of the Revolving Credit Facility.

The Company is required to meet certain financial covenants in connection with the Revolving Credit Facility, including maintaining specific liquidity measurements. There are also negative covenants, including certain restrictions on the Company’s and its subsidiaries’ ability to incur additional indebtedness, create liens, make investments, consolidate, or merge with other entities, enter into transactions with affiliates, make prepayments with respect to certain indebtedness, make dividend payments, loans, or advances to the Company, declare dividends and make restricted payments and other distributions.

As of March 30, 2024, there were no outstanding borrowings on the Revolving Credit Facility and $75.0 million was available for future borrowing.

Term Loan

The Term Loan matures on February 23, 2029. The Term Loan bears interest, at the borrower’s option, at a rate per annum based on Term SOFR (as defined in the Credit Agreement), plus a margin ranging from 3.75% to 4.00%, depending on the First Lien Net Leverage Ratio, or based on the Base Rate (as defined in the Credit Agreement), plus a margin ranging from 2.75% to 3.00%, depending on the First Lien Net Leverage Ratio. The Term Loan is subject to scheduled quarterly amortization payments of $812,500, equal to 0.25% of the initial principal amount of the Term Loan. The Credit Agreement contains customary mandatory prepayment provisions for the Term Loan, including requirements to make mandatory prepayments with 50% of any excess cash flow and with 100% of the net cash proceeds from the incurrence of indebtedness not otherwise permitted to be incurred by the covenants, asset sales, and casualty and condemnation events, in each case, subject to customary exceptions.

During the quarter ended March 30, 2024, the Company made a payment of $18.0 million.

Outstanding borrowings as of March 30, 2024 were $282.8 million, net of unamortized discount and debt issuance costs of $7.7 million. In connection with the Term Loan, the Company is subject to various negative, reporting, financial, and other covenants, including maintaining specific liquidity measurements.

As of March 30, 2024, the unamortized debt issuance costs and discount on the Term Loan were $4.3 million and $3.4 million, respectively. The effective interest rate was 9.89% at March 30, 2024, including the impact of the Company’s interest rate swaps.

Interest Rate Risk

Interest rate risk associated with the Credit Agreement is mitigated partially through interest rate swaps.

The Company executed an interest rate swap on April 30, 2020. The swap had an effective date of May 18, 2020 and a termination date of May 18, 2023. In February 2022, the Company amended its interest rate swap to change the index rate from LIBOR to SOFR in connection with the entry into the Credit Agreement. Under the terms of the amended swap, the Company fixed its SOFR borrowing rate at 0.496% on a notional amount of $200.0 million. The interest rate swap was not designated as a hedging instrument for accounting purposes (see Note 3).

Additionally, the Company entered into an interest rate swap that was executed on March 10, 2023. The swap has an effective date of May 18, 2023 and a termination date of May 18, 2026. Under the terms of the swap, the Company fixed its SOFR borrowing rate at 4.3725% on a notional amount of $161.0 million. The interest rate swap is not designated as a hedging instrument for accounting purposes (see Note 3).

Debt Maturities

Principal payments due on the outstanding debt, excluding the Revolving Credit Facility, in the next five fiscal years, excluding any potential payments based on excess cash flow, are as follows (in thousands):

Year Ended

Term Loan

Remainder of fiscal year 2024

    

$

2,438

2025

 

3,250

2026

 

3,250

2027

 

3,250

2028

3,250

Thereafter

 

275,062

$

290,500

Guarantees

The obligations under the Credit Agreement are guaranteed by certain wholly owned subsidiaries (the “Guarantors”) of the Company as defined in the security agreement. The obligations under the Credit Agreement are secured by substantially all of the Guarantors’ tangible and intangible assets, including their accounts receivables, equipment, intellectual property, inventory, cash and cash equivalents, deposit accounts, and security accounts. The Credit Agreement also restricts payments and other distributions unless certain conditions are met, which could restrict the Company’s ability to pay dividends.

v3.24.1.u1
PRODUCT WARRANTIES
3 Months Ended
Mar. 30, 2024
PRODUCT WARRANTIES  
PRODUCT WARRANTIES

7. PRODUCT WARRANTIES

The warranty reserve activity consisted of the following (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Balance at the beginning of the fiscal year

$

3,161

$

3,990

Adjustments to reserve

 

537

 

354

Less: Settlements made (in cash or in kind)

 

(679)

 

(761)

Balance at the end of the fiscal quarter

$

3,019

$

3,583

v3.24.1.u1
LEASES
3 Months Ended
Mar. 30, 2024
LEASES  
LEASES

8. LEASES

For leases with initial terms greater than 12 months, the Company considers these right-of-use assets and records the related asset and obligation at the present value of lease payments over the term. For leases with initial terms equal to or less than 12 months, the Company does not consider them as right-of-use assets and instead considers them short-term lease costs that are recognized on a straight-line basis over the lease term. The Company’s leases may include escalation clauses, renewal options, and/or termination options that are factored into the Company’s determination of lease term and lease payments when it is reasonably certain the option will be exercised. The Company elected to take the practical expedient and not separate lease and non-lease components of contracts. The Company estimates an incremental borrowing rate to discount the lease payments based on information available at lease commencement because the implicit rate of the lease is generally not known.

The Company leases manufacturing facilities, office space, land, and certain vehicles and equipment under operating leases. The Company also leases certain vehicles and equipment under finance leases. The Company determines if an arrangement is a lease at inception. A contract is or contains a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration.

The components of lease expense for the fiscal quarters ended March 30, 2024 and April 1, 2023 were as follows (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Operating lease expense

$

2,163

$

2,351

Finance lease amortization of assets

212

109

Finance lease interest on lease liabilities

84

52

Short-term lease expense

 

56

 

54

Variable lease expense

 

158

 

327

Total lease expense

$

2,673

$

2,893

Operating and finance lease right-of-use assets and lease-related liabilities as of March 30, 2024 and December 31, 2023 were as follows (in thousands):

March 30, 2024

December 31, 2023

Classification

Lease right-of-use assets:

Operating leases

$

28,696

$

30,788

Operating lease right-of-use assets

Finance leases

3,887

3,912

Other assets

Total lease right-of-use assets

$

32,583

$

34,700

Lease-related liabilities

Current

Operating leases

$

6,823

$

7,133

Current operating lease liabilities

Finance leases

782

746

Accrued expenses and other current liabilities

Non-current

Operating leases

22,963

24,787

Non-current operating lease liabilities

Finance leases

3,247

3,285

Other long-term liabilities

Total lease liabilities

$

33,815

$

35,951

The table below presents supplemental information related to leases as of March 30, 2024 and December 31, 2023:

    

March 30, 2024

December 31, 2023

Weighted-average remaining lease term (years)

Finance leases

5.0

5.2

Operating leases

5.6

5.7

Weighted-average discount rate

Finance leases

8.2

%

8.2

%

Operating leases

5.0

%

5.1

%

The table below presents supplemental information related to the cash flows for operating leases recorded on the condensed consolidated statements of cash flows (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows for operating leases

$

1,794

$

1,817

The following table summarizes maturities of operating lease liabilities as of March 30, 2024 (in thousands):

    

Operating Leases

Finance Leases

Total

Remainder of fiscal year 2024

$

6,260

$

813

$

7,073

2025

7,309

1,030

8,339

2026

5,805

934

6,739

2027

4,097

858

4,955

2028

3,111

845

3,956

Thereafter

7,637

436

8,073

Total lease payments

34,219

4,916

39,135

Less: Interest

(4,433)

(886)

(5,319)

Present value of lease liability

$

29,786

$

4,030

$

33,816

v3.24.1.u1
NET SALES
3 Months Ended
Mar. 30, 2024
NET SALES.  
NET SALES

9. NET SALES

The following table sets forth the Company’s disaggregation of net sales by product line (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

In-ground Swimming Pools

$

59,832

$

78,612

Covers

 

26,868

 

32,745

Liners

 

23,929

 

26,362

$

110,629

$

137,719

v3.24.1.u1
INCOME TAXES
3 Months Ended
Mar. 30, 2024
INCOME TAXES  
INCOME TAXES

10. INCOME TAXES

The effective income tax rate for the fiscal quarter ended March 30, 2024 was (7.2)% compared to 16.9% for the fiscal quarter ended April 1, 2023. The differences between the U.S. federal statutory income tax rate and our effective income tax rates for the fiscal quarter ended March 30, 2024 and the fiscal quarter ended April 1, 2023 were primarily attributable to the discrete impact of stock compensation expense for which there is no associated tax benefit.

v3.24.1.u1
STOCKHOLDERS' EQUITY
3 Months Ended
Mar. 30, 2024
STOCKHOLDERS' EQUITY  
STOCKHOLDERS' EQUITY

11. STOCKHOLDERS’ EQUITY

Repurchase Program

On May 10, 2022, the Board of Directors of the Company approved a stock repurchase program (the “Repurchase Program”), which authorizes the Company to repurchase up to $100 million of the Company’s shares of common stock by May 2025. The Company may effect these repurchases in open market transactions, privately negotiated purchases, or other acquisitions. The Company is not obligated to repurchase any of its shares of its common stock under the Repurchase Program and the timing and amount of any repurchases will depend on market conditions, the Company’s stock price, alternative uses of capital, the terms of the Company’s debt instruments, and other factors.

As of March 30, 2024, $77.0 million remained available for share repurchases pursuant to the Repurchase Program. The Company did not repurchase any shares of its common stock during the fiscal quarter ended March 30, 2024. The Company accounts for the excess of the repurchase price over the par value of shares acquired as a reduction to additional paid-in capital.

v3.24.1.u1
STOCK-BASED COMPENSATION
3 Months Ended
Mar. 30, 2024
STOCK-BASED COMPENSATION  
STOCK-BASED COMPENSATION

12. STOCK-BASED COMPENSATION

On April 12, 2021, the Company’s stockholders approved the 2021 Omnibus Equity Incentive Plan (the “2021 Omnibus Equity Plan”), which became effective on April 22, 2021, upon pricing of its initial public offering. The 2021 Omnibus Equity Plan provides for the issuance of incentive stock options, non-qualified stock options, stock appreciation rights, restricted stock, restricted stock units, performance stock units and other stock-based and cash-based awards. The maximum grant date fair value of cash and equity awards that may be awarded to a non-employee director under the 2021 Omnibus Equity Plan during any one fiscal year, together with any cash fees paid to such non-employee director during such fiscal year, is $750,000.

On May 2, 2023, at the 2023 annual meeting of stockholders of the Company, the stockholders approved the first amendment (the “First Amendment”) to the 2021 Omnibus Equity Plan, which was previously approved by the Board of Directors of the Company. The First Amendment became effective upon stockholder approval, and included an increase by 8,000,000 shares of the share pool, i.e. the maximum number of shares of the Company’s common stock that may be issued pursuant to awards granted under the 2021 Omnibus Equity Plan.

Except as amended by the First Amendment, the other terms of the 2021 Omnibus Equity Plan remain in full force and effect. Subsequent to the First Amendment, the maximum aggregate number of shares reserved for issuance under the 2021 Omnibus Equity Plan is 21,170,212 shares.

The following table summarizes the Company’s stock-based compensation expense (in thousands):

Fiscal Quarter Ended

March 30, 2024

    

April 1, 2023

Cost of sales

$

$

426

Selling, general, and administrative

 

1,243

 

6,343

$

1,243

$

6,769

As of March 30, 2024, total unrecognized stock-based compensation expense related to all unvested stock-based awards was $13.3 million, which is expected to be recognized over a weighted-average period of 2.2 years.

Restricted Stock Awards

The following table represents the Company’s restricted stock awards activity during the fiscal quarter ended March 30, 2024:

Weighted-

Average Grant-

    

Shares

    

Date Fair Value

Outstanding at January 1, 2024

 

42,886

$

19.00

Granted

 

 

Vested

 

 

Forfeited

 

 

Outstanding at March 30, 2024

 

42,886

$

19.00

Restricted Stock Units

The following table represents the Company’s restricted stock units activity during the fiscal quarter ended March 30, 2024:

    

    

Weighted-

Average Grant-

Shares

Date Fair Value

Outstanding at January 1, 2024

 

2,235,479

$

3.60

Granted

 

2,282,336

 

2.87

Vested

 

(411,301)

 

3.94

Forfeited

 

(85,392)

 

2.93

Outstanding at March 30, 2024

 

4,021,122

$

3.17

Stock Options

The following table represents the Company’s stock option activity during the fiscal quarter ended March 30, 2024:

    

Weighted-

    

Weighted-

    

Average 

Average 

Exercise Price

Remaining 

Aggregate 

    

Shares

    

 per Share

    

Contract Term

    

Intrinsic Value

 

 

(in years)

(in thousands)

Outstanding at January 1, 2024

 

1,554,294

$

15.43

 

Granted

 

 

  

 

  

Exercised

 

 

 

  

 

  

Forfeited

 

(42,004)

 

16.92

 

  

 

  

Expired

(57,616)

17.78

Outstanding at March 30, 2024

 

1,454,674

$

15.30

 

7.58

$

Vested and expected to vest at March 30, 2024

 

1,454,674

$

15.30

 

7.58

$

Options exercisable at March 30, 2024

 

678,477

$

16.10

 

7.38

$

The aggregate intrinsic value of stock options is calculated as the difference between the exercise price of the stock options and the fair value of the Company’s common stock for those stock options that had exercise prices lower than the fair value of the Company’s common stock.

Stock Appreciation Rights

During the fiscal quarter ended April 1, 2023, as a portion of the annual equity award grants to the Company’s executive officers, the Compensation Committee of the Board of Directors approved stock appreciation rights for an aggregate of 790,181 shares of the Company’s common stock, with a strike price of $3.24 per share. At the time of such approval, the Company did not have enough shares of the Company’s common stock in the share pool under the 2021 Omnibus Equity Plan to support such grant. As of April 1, 2023, the contingent grant of stock appreciation rights remained subject to stockholder approval of the First Amendment. On May 2, 2023, following stockholder approval of the First Amendment, the foregoing stock appreciation right awards became effective without condition.

The following table represents the Company’s stock appreciation rights activity during the fiscal quarter ended March 30, 2024:

    

Weighted-

    

Weighted-

    

Average 

Average 

Exercise Price

Remaining 

Aggregate 

    

Shares

    

 per Share

    

Contract Term

    

Intrinsic Value

 

 

(in years)

(in thousands)

Outstanding at January 1, 2024

 

755,802

$

3.16

 

Granted

 

 

  

 

  

Exercised

 

 

 

  

 

  

Forfeited

 

(49,342)

 

3.24

 

  

 

  

Outstanding at March 30, 2024

 

706,460

$

3.15

 

9.13

$

569,296

Vested and expected to vest at March 30, 2024

 

706,460

$

3.15

 

9.13

$

569,296

Stock appreciation rights exercisable at March 30, 2024

 

161,893

$

3.24

 

9.09

$

116,563

The aggregate intrinsic value of stock appreciation rights is calculated as the difference between the strike price of the stock appreciation rights and the fair value of the Company’s common stock for those stock appreciation rights that had strike prices lower than the fair value of the Company’s common stock.

No stock appreciation rights were granted under this plan during the fiscal quarter ended March 30, 2024.

Performance Stock Units

During the fiscal quarter ended March 30, 2024 the Compensation Committee of the Board of Directors approved the grant of performance stock units (“PSUs”) as a portion of the annual equity award to the Company’s executive officers for an aggregate of 427,145 shares of the Company’s common stock.

The PSUs will be earned at 0% to 200% of the target PSUs (with 100% of PSUs being earned at target performance, and linear interpolation between threshold and target and maximum performance) based on the Company’s achievement of Adjusted EBITDA, as defined in the award agreement, over a one-year performance period ending December 31, 2024. Any earned PSUs cliff vest on the third anniversary of the grant date. Adjusted EBITDA is considered a performance condition and the grant date fair value corresponds with management’s expectation of the probable outcome of the performance condition as of the grant date. The grant date fair value is determined based on the fair market value of the Company’s stock at market close on the grant date multiplied by the target number of shares subject to the award. The probability of achieving the performance criteria is assessed quarterly during the performance period. Compensation expense related to unvested PSUs is recognized ratably over the service period.

The following table represents the Company’s PSU activity during the fiscal quarter ended March 30, 2024:

    

 

Weighted-

 

Average 

 

Grant Date

    

Shares

    

 

Fair Value

 

 

Outstanding at January 1, 2024

 

$

Granted

 

427,145

2.87

Adjustment for expected performance achievement (1)

 

Forfeited

 

Outstanding at March 30, 2024 (2)

 

427,145

$

2.87

(1)Represents the adjustment to previously granted PSUs based on performance expectations as of the end of each respective fiscal year.
(2)An additional 427,145 PSUs could potentially be included if the maximum performance level of 200% is earned for all PSUs outstanding as of March 30, 2024.
v3.24.1.u1
NET LOSS PER SHARE
3 Months Ended
Mar. 30, 2024
NET LOSS PER SHARE  
NET LOSS PER SHARE

13. NET LOSS PER SHARE

Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share data):

Fiscal Quarter Ended

    

    

March 30, 2024

    

April 1, 2023

Numerator:

  

  

Net loss attributable to common stockholders

$

(7,864)

$

(14,368)

Denominator:

 

  

 

  

Weighted-average common shares outstanding

 

Basic

115,038,929

112,102,198

Diluted

115,038,929

112,102,198

Net loss per share attributable to common stockholders:

Basic

$

(0.07)

$

(0.13)

Diluted

$

(0.07)

$

(0.13)

As of March 30, 2024 and December 31, 2023, 115,346,803 and 114,828,896 shares of common stock were issued and outstanding for accounting purposes, respectively.

The following table includes the number of shares that may be dilutive common shares in the future that were not included in the computation of diluted net loss per share because the effect was anti-dilutive:

    

    

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Restricted stock awards

 

42,886

 

2,576,219

Restricted stock units

 

24,146

 

500,751

Stock options

 

1,521,158

 

1,886,497

Stock appreciation rights

657,999

Performance stock units

75,937

v3.24.1.u1
RELATED PARTY TRANSACTIONS
3 Months Ended
Mar. 30, 2024
RELATED PARTY TRANSACTIONS  
RELATED PARTY TRANSACTIONS

14. RELATED PARTY TRANSACTIONS

BrightAI Services

Starting in 2020, BrightAI Corporation (“BrightAI”) has rendered services to the Company, for which the cost has been capitalized as internal-use software. A co-founder of BrightAI Services served on the Company’s Board of Directors from December 9, 2020 until his resignation on February 21, 2024. In December 2022, the Company executed an additional agreement with BrightAI for the provision of hardware to run the technology developed by BrightAI and the Company. The Company had no material transactions with BrightAI during the quarters ended March 30, 2024 and April 1, 2023. As of December 31, 2023, the Company had no accounts payable related to BrightAI.

v3.24.1.u1
RESTRUCTURING COSTS
3 Months Ended
Mar. 30, 2024
RESTRUCTURING COSTS  
RESTRUCTURING COSTS

15. RESTRUCTURING COSTS

During the second and third fiscal quarters of 2023, the Company initiated an additional plan focused on efforts to improve efficiencies and decrease costs. The plan involved a reduction in the Company’s workforce as well as closures of various manufacturing facilities. The Company had an exit or disposal cost related liability of $0.1 million as of March 30, 2024 and $0.2 million as of December 31, 2023.

v3.24.1.u1
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
3 Months Ended
Mar. 30, 2024
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES  
Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements and accompanying notes have been prepared in accordance with generally accepted accounting principles in the United States (“GAAP”). The Company’s unaudited condensed consolidated financial statements include the accounts of the Company and its subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.

Unaudited Interim Financial Information

The unaudited condensed consolidated balance sheet at December 31, 2023 was derived from audited financial statements but does not include all disclosures required by GAAP. The accompanying unaudited condensed consolidated financial statements as of March 30, 2024 and for the fiscal quarters ended March 30, 2024 and April 1, 2023, respectively, have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial statements. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. These condensed consolidated financial statements should be read in conjunction with Latham Group, Inc.’s audited consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2023 included in the Company’s 2023 Annual Report on Form 10-K, filed with the SEC on March 13, 2024 (the “Annual Report”). In the opinion of management, all adjustments, consisting only of normal recurring adjustments necessary for a fair statement of these condensed consolidated financial statements, have been included. The Company’s results of operations for the fiscal quarter ended March 30, 2024 are not necessarily indicative of the results of operations that may be expected for the fiscal year ending December 31, 2024 or other interim periods thereof.

Use of Estimates

Use of Estimates

The preparation of the Company’s condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates. The Company bases its estimates on historical experience, known trends, and other market-specific relevant factors that it believes to be reasonable under the circumstances. Estimates are evaluated on an ongoing basis and revised as there are changes in circumstances, facts, and experience. Changes in estimates are recorded in the period in which they become known.

Reclassifications

Reclassifications

Certain prior period balances have been reclassified to conform to the current period presentation in the condensed consolidated financial statements and the accompanying notes.

Seasonality

Seasonality

Although the Company generally has demand for its products throughout the fiscal year, its business is seasonal and weather is one of the principal external factors affecting the business. Historically, net sales and net income are highest (or net loss is lowest) during the second and third fiscal quarters, representing the peak months of swimming pool use, pool installation, and remodeling and repair activities. Severe weather may also affect net sales in all periods.

Significant Accounting Policies

Significant Accounting Policies

Refer to the Annual Report for a discussion of the Company’s significant accounting policies, as updated below.

Recently Issued Accounting Pronouncements

Recently Issued Accounting Pronouncements

The Company qualifies as “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012 and has elected to “opt in” to the extended transition related to complying with new or revised accounting standards, which means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, the Company will adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and will do so until such time that the Company either (i) irrevocably elects to “opt out” of such extended transition period or (ii) no longer qualifies as an emerging growth company. The Company may choose to early adopt any new or revised accounting standards whenever such early adoption is permitted for private companies.

In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures (“ASU 2023-07”), which improves financial reporting by requiring disclosure of incremental segment information on an annual and interim basis for all public entities to enable investors to develop more decision-useful analysis. For all entities, ASU 2023-07 is effective for fiscal years beginning after December 15, 2023. The amendments should be applied retrospectively to all prior periods presented in the financial statements, with early adoption permitted. The Company is currently evaluating ASU 2023-07 and its potential impact on the notes to the condensed consolidated financial statements.

In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures (“ASU 2023-09”), in an effort to enhance the transparency and decision usefulness of income tax disclosures. For all entities, ASU 2023-09 is effective for fiscal years beginning after December 15, 2024. The amendments should be applied prospectively with retrospective application permitted. Early adoption is also permitted. The Company is currently evaluating ASU 2023-09 and its potential impact on the notes to the condensed consolidated financial statements.

In March 2024, the FASB issued ASU 2024-01, Compensation – Stock Compensation (Topic 718): Scope Application of Profits Interest and Similar Awards (“ASU 2024-01”), which improves financial reporting by providing clarity on when an entity should apply the scope guidance in paragraph 718-10-15-3. For all public entities, ASU 2024-01 is effective for fiscal years beginning after December 15, 2024. The amendments should be applied retrospectively to all prior periods presented in the financial statements, with early adoption permitted. The Company is currently evaluating ASU 2024-01 and its potential impact on the notes to the condensed consolidated financial statements.

v3.24.1.u1
FAIR VALUE MEASUREMENTS (Tables)
3 Months Ended
Mar. 30, 2024
FAIR VALUE MEASUREMENTS  
Schedule of financial liabilities at fair value on a recurring basis The following table sets forth the carrying amount and fair value of its term loan (in thousands):

March 30, 2024

December 31, 2023

Carrying

Estimated

Carrying

Estimated

    

Value

    

Fair Value

    

Value

    

Fair Value

Term Loan

$

282,781

$

277,832

$

301,201

$

289,153

v3.24.1.u1
GOODWILL AND INTANGIBLE ASSETS, NET (Tables)
3 Months Ended
Mar. 30, 2024
GOODWILL AND INTANGIBLE ASSETS, NET  
Schedule of Intangible assets

Intangible assets, net as of March 30, 2024 consisted of the following (in thousands):

March 30, 2024

Gross 

Foreign 

Carrying 

Currency 

Accumulated 

Net 

    

Amount

    

Translation

    

Amortization

    

Amount

Trade names and trademarks

$

148,100

$

(251)

$

31,233

$

116,616

Patented technology

 

16,126

 

(4)

 

9,111

 

7,011

Technology

13,000

2,023

10,977

Pool designs

 

13,628

 

(124)

 

3,207

 

10,297

Franchise relationships

 

1,187

 

 

1,187

 

Dealer relationships

 

197,376

 

(1)

 

66,400

 

130,975

Order backlog

1,600

1,600

Non-competition agreements

 

2,476

 

 

2,476

 

$

393,493

$

(380)

$

117,237

$

275,876

Intangible assets, net as of December 31, 2023 consisted of the following (in thousands):

December 31, 2023

Gross 

Foreign 

Carrying 

Currency 

Accumulated 

Net 

    

Amount

    

Translation

    

Amortization

    

Amount

Trade names and trademarks

$

148,100

$

72

$

29,583

$

118,589

Patented technology

 

16,126

 

1

 

8,713

 

7,414

Technology

13,000

1,806

11,194

Pool designs

 

13,628

 

35

 

2,973

 

10,690

Franchise relationships

 

1,187

 

 

1,187

 

Dealer relationships

 

197,376

 

 

62,470

 

134,906

Order backlog

1,600

1,600

Non-competition agreements

 

2,476

 

 

2,476

 

$

393,493

$

108

$

110,808

$

282,793

Schedule of estimated amortization expense related to definite-lived intangible assets

The Company estimates that amortization expense related to definite-lived intangible assets will be as follows in each of the next five years and thereafter (in thousands):

Estimated Future 

Amortization 

Year Ended

    

Expense

Remainder of fiscal year 2024

$

19,282

2025

 

25,551

2026

 

25,551

2027

 

25,551

2028

 

24,593

Thereafter

 

155,348

$

275,876

v3.24.1.u1
INVENTORIES, NET (Tables)
3 Months Ended
Mar. 30, 2024
INVENTORIES, NET  
Schedule of inventories, net

Inventories, net consisted of the following (in thousands):

    

March 30, 2024

    

December 31, 2023

Raw materials

$

53,145

$

55,081

Finished goods

 

42,006

 

42,056

$

95,151

$

97,137

v3.24.1.u1
LONG-TERM DEBT (Tables)
3 Months Ended
Mar. 30, 2024
LONG-TERM DEBT  
Schedule of components of the Company's outstanding debt obligations

The components of the Company’s outstanding long-term debt obligations consisted of the following (in thousands):

    

March 30, 2024

    

December 31, 2023

Term Loan

$

290,500

$

309,313

Revolving Credit Facility

Less: Unamortized discount and debt issuance costs

 

(7,719)

 

(8,112)

Total debt

 

282,781

 

301,201

Less: Current portion of long-term debt

 

(3,250)

 

(21,250)

Total long-term debt

$

279,531

$

279,951

Schedule of principal payments due on the outstanding debt

Principal payments due on the outstanding debt, excluding the Revolving Credit Facility, in the next five fiscal years, excluding any potential payments based on excess cash flow, are as follows (in thousands):

Year Ended

Term Loan

Remainder of fiscal year 2024

    

$

2,438

2025

 

3,250

2026

 

3,250

2027

 

3,250

2028

3,250

Thereafter

 

275,062

$

290,500

v3.24.1.u1
PRODUCT WARRANTIES (Tables)
3 Months Ended
Mar. 30, 2024
PRODUCT WARRANTIES  
Schedule of warranty reserve activity

The warranty reserve activity consisted of the following (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Balance at the beginning of the fiscal year

$

3,161

$

3,990

Adjustments to reserve

 

537

 

354

Less: Settlements made (in cash or in kind)

 

(679)

 

(761)

Balance at the end of the fiscal quarter

$

3,019

$

3,583

v3.24.1.u1
LEASES (Tables)
3 Months Ended
Mar. 30, 2024
LEASES  
Summary of components of lease expense

The components of lease expense for the fiscal quarters ended March 30, 2024 and April 1, 2023 were as follows (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Operating lease expense

$

2,163

$

2,351

Finance lease amortization of assets

212

109

Finance lease interest on lease liabilities

84

52

Short-term lease expense

 

56

 

54

Variable lease expense

 

158

 

327

Total lease expense

$

2,673

$

2,893

Schedule of supplemental lease information

Operating and finance lease right-of-use assets and lease-related liabilities as of March 30, 2024 and December 31, 2023 were as follows (in thousands):

March 30, 2024

December 31, 2023

Classification

Lease right-of-use assets:

Operating leases

$

28,696

$

30,788

Operating lease right-of-use assets

Finance leases

3,887

3,912

Other assets

Total lease right-of-use assets

$

32,583

$

34,700

Lease-related liabilities

Current

Operating leases

$

6,823

$

7,133

Current operating lease liabilities

Finance leases

782

746

Accrued expenses and other current liabilities

Non-current

Operating leases

22,963

24,787

Non-current operating lease liabilities

Finance leases

3,247

3,285

Other long-term liabilities

Total lease liabilities

$

33,815

$

35,951

The table below presents supplemental information related to leases as of March 30, 2024 and December 31, 2023:

    

March 30, 2024

December 31, 2023

Weighted-average remaining lease term (years)

Finance leases

5.0

5.2

Operating leases

5.6

5.7

Weighted-average discount rate

Finance leases

8.2

%

8.2

%

Operating leases

5.0

%

5.1

%

The table below presents supplemental information related to the cash flows for operating leases recorded on the condensed consolidated statements of cash flows (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Cash paid for amounts included in the measurement of lease liabilities:

Operating cash flows for operating leases

$

1,794

$

1,817

Summary of maturities of operating lease liabilities

The following table summarizes maturities of operating lease liabilities as of March 30, 2024 (in thousands):

    

Operating Leases

Finance Leases

Total

Remainder of fiscal year 2024

$

6,260

$

813

$

7,073

2025

7,309

1,030

8,339

2026

5,805

934

6,739

2027

4,097

858

4,955

2028

3,111

845

3,956

Thereafter

7,637

436

8,073

Total lease payments

34,219

4,916

39,135

Less: Interest

(4,433)

(886)

(5,319)

Present value of lease liability

$

29,786

$

4,030

$

33,816

v3.24.1.u1
NET SALES (Tables)
3 Months Ended
Mar. 30, 2024
NET SALES.  
Summary of disaggregation of net sales by product line

The following table sets forth the Company’s disaggregation of net sales by product line (in thousands):

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

In-ground Swimming Pools

$

59,832

$

78,612

Covers

 

26,868

 

32,745

Liners

 

23,929

 

26,362

$

110,629

$

137,719

v3.24.1.u1
STOCK-BASED COMPENSATION (Tables)
3 Months Ended
Mar. 30, 2024
STOCK-BASED COMPENSATION  
Summary of stock-based compensation expense

The following table summarizes the Company’s stock-based compensation expense (in thousands):

Fiscal Quarter Ended

March 30, 2024

    

April 1, 2023

Cost of sales

$

$

426

Selling, general, and administrative

 

1,243

 

6,343

$

1,243

$

6,769

Schedule of restricted stock awards

The following table represents the Company’s restricted stock awards activity during the fiscal quarter ended March 30, 2024:

Weighted-

Average Grant-

    

Shares

    

Date Fair Value

Outstanding at January 1, 2024

 

42,886

$

19.00

Granted

 

 

Vested

 

 

Forfeited

 

 

Outstanding at March 30, 2024

 

42,886

$

19.00

Schedule of restricted stock units

The following table represents the Company’s restricted stock units activity during the fiscal quarter ended March 30, 2024:

    

    

Weighted-

Average Grant-

Shares

Date Fair Value

Outstanding at January 1, 2024

 

2,235,479

$

3.60

Granted

 

2,282,336

 

2.87

Vested

 

(411,301)

 

3.94

Forfeited

 

(85,392)

 

2.93

Outstanding at March 30, 2024

 

4,021,122

$

3.17

Schedule of stock option activity

The following table represents the Company’s stock option activity during the fiscal quarter ended March 30, 2024:

    

Weighted-

    

Weighted-

    

Average 

Average 

Exercise Price

Remaining 

Aggregate 

    

Shares

    

 per Share

    

Contract Term

    

Intrinsic Value

 

 

(in years)

(in thousands)

Outstanding at January 1, 2024

 

1,554,294

$

15.43

 

Granted

 

 

  

 

  

Exercised

 

 

 

  

 

  

Forfeited

 

(42,004)

 

16.92

 

  

 

  

Expired

(57,616)

17.78

Outstanding at March 30, 2024

 

1,454,674

$

15.30

 

7.58

$

Vested and expected to vest at March 30, 2024

 

1,454,674

$

15.30

 

7.58

$

Options exercisable at March 30, 2024

 

678,477

$

16.10

 

7.38

$

Schedule of stock appreciation rights activity

The following table represents the Company’s stock appreciation rights activity during the fiscal quarter ended March 30, 2024:

    

Weighted-

    

Weighted-

    

Average 

Average 

Exercise Price

Remaining 

Aggregate 

    

Shares

    

 per Share

    

Contract Term

    

Intrinsic Value

 

 

(in years)

(in thousands)

Outstanding at January 1, 2024

 

755,802

$

3.16

 

Granted

 

 

  

 

  

Exercised

 

 

 

  

 

  

Forfeited

 

(49,342)

 

3.24

 

  

 

  

Outstanding at March 30, 2024

 

706,460

$

3.15

 

9.13

$

569,296

Vested and expected to vest at March 30, 2024

 

706,460

$

3.15

 

9.13

$

569,296

Stock appreciation rights exercisable at March 30, 2024

 

161,893

$

3.24

 

9.09

$

116,563

Schedule of PSU activity

The following table represents the Company’s PSU activity during the fiscal quarter ended March 30, 2024:

    

 

Weighted-

 

Average 

 

Grant Date

    

Shares

    

 

Fair Value

 

 

Outstanding at January 1, 2024

 

$

Granted

 

427,145

2.87

Adjustment for expected performance achievement (1)

 

Forfeited

 

Outstanding at March 30, 2024 (2)

 

427,145

$

2.87

(1)Represents the adjustment to previously granted PSUs based on performance expectations as of the end of each respective fiscal year.
(2)An additional 427,145 PSUs could potentially be included if the maximum performance level of 200% is earned for all PSUs outstanding as of March 30, 2024.
v3.24.1.u1
NET LOSS PER SHARE (Tables)
3 Months Ended
Mar. 30, 2024
NET LOSS PER SHARE  
Schedule of basic and diluted net loss per share

Basic and diluted net loss per share attributable to common stockholders was calculated as follows (in thousands, except share and per share data):

Fiscal Quarter Ended

    

    

March 30, 2024

    

April 1, 2023

Numerator:

  

  

Net loss attributable to common stockholders

$

(7,864)

$

(14,368)

Denominator:

 

  

 

  

Weighted-average common shares outstanding

 

Basic

115,038,929

112,102,198

Diluted

115,038,929

112,102,198

Net loss per share attributable to common stockholders:

Basic

$

(0.07)

$

(0.13)

Diluted

$

(0.07)

$

(0.13)

Schedule of antidilutive securities excluded from computation of diluted net loss per share

    

    

Fiscal Quarter Ended

    

March 30, 2024

    

April 1, 2023

Restricted stock awards

 

42,886

 

2,576,219

Restricted stock units

 

24,146

 

500,751

Stock options

 

1,521,158

 

1,886,497

Stock appreciation rights

657,999

Performance stock units

75,937

v3.24.1.u1
NATURE OF THE BUSINESS (Details)
$ in Millions
Apr. 27, 2021
USD ($)
shares
Apr. 13, 2021
Business Acquisition [Line Items]    
Stock split ratio   109,673.709
IPO    
Business Acquisition [Line Items]    
Proceeds from sale of common stock (in shares) 23,000,000  
Net proceeds from the IPO | $ $ 399.3  
Underwriters Option    
Business Acquisition [Line Items]    
Proceeds from sale of common stock (in shares) 3,000,000  
v3.24.1.u1
FAIR VALUE MEASUREMENTS - Fair value of financial instruments (Details) - Level 2 - USD ($)
$ in Thousands
Mar. 30, 2024
Dec. 31, 2023
Term Loan | Carrying Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Amount $ 282,781 $ 301,201
Term Loan | Estimated Fair Value    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Amount 277,832 289,153
Interest rate swap    
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]    
Fair value of interest rate swap asset $ 600  
Fair value of interest rate swap liability   $ 1,200
v3.24.1.u1
GOODWILL AND INTANGIBLE ASSETS, NET - Goodwill (Details) - USD ($)
$ in Thousands
Mar. 30, 2024
Dec. 31, 2023
GOODWILL AND INTANGIBLE ASSETS, NET    
Goodwill $ 130,987 $ 131,363
v3.24.1.u1
GOODWILL AND INTANGIBLE ASSETS, NET - Intangible Assets (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount $ 393,493   $ 393,493
Foreign Currency Translation (380)   108
Accumulated Amortization 117,237   110,808
Net Amount 275,876   282,793
Amortization of Intangible Assets 6,412 $ 6,632  
Trade names and trademarks      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 148,100   148,100
Foreign Currency Translation (251)   72
Accumulated Amortization 31,233   29,583
Net Amount 116,616   118,589
Patented technology      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 16,126   16,126
Foreign Currency Translation (4)   1
Accumulated Amortization 9,111   8,713
Net Amount 7,011   7,414
Technology      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 13,000   13,000
Accumulated Amortization 2,023   1,806
Net Amount 10,977   11,194
Pool designs      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 13,628   13,628
Foreign Currency Translation (124)   35
Accumulated Amortization 3,207   2,973
Net Amount 10,297   10,690
Franchise relationships      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 1,187   1,187
Accumulated Amortization 1,187   1,187
Dealer relationships      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 197,376   197,376
Foreign Currency Translation (1)    
Accumulated Amortization 66,400   62,470
Net Amount 130,975   134,906
Order backlog      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 1,600   1,600
Accumulated Amortization 1,600   1,600
Non-competition agreements      
Finite-Lived Intangible Assets [Line Items]      
Gross Carrying Amount 2,476   2,476
Accumulated Amortization $ 2,476   $ 2,476
v3.24.1.u1
GOODWILL AND INTANGIBLE ASSETS, NET - Amortization Expense (Details) - USD ($)
$ in Thousands
Mar. 30, 2024
Dec. 31, 2023
Finite-Lived Intangible Assets, Net, Amortization Expense, Fiscal Year Maturity [Abstract]    
Remainder of fiscal year 2024 $ 19,282  
2025 25,551  
2026 25,551  
2027 25,551  
2028 24,593  
Thereafter 155,348  
Net Amount $ 275,876 $ 282,793
v3.24.1.u1
INVENTORIES, NET (Details) - USD ($)
$ in Thousands
Mar. 30, 2024
Dec. 31, 2023
INVENTORIES, NET    
Raw materials $ 53,145 $ 55,081
Finished goods 42,006 42,056
Inventory, net, Total $ 95,151 $ 97,137
v3.24.1.u1
LONG-TERM DEBT (Details) - USD ($)
$ in Thousands
Mar. 30, 2024
Dec. 31, 2023
Feb. 23, 2022
Debt Instrument [Line Items]      
Gross debt $ 290,500    
Less: Unamortized discount and debt issuance costs (7,719) $ (8,112)  
Total debt 282,781 301,201  
Less: Current portion of long-term debt (3,250) (21,250)  
Total long-term debt 279,531 279,951  
Revolving Credit Facility      
Debt Instrument [Line Items]      
Maximum borrowing capacity 75,000   $ 75,000
Term Loan      
Debt Instrument [Line Items]      
Gross debt $ 290,500 $ 309,313  
Maximum borrowing capacity     $ 325,000
v3.24.1.u1
LONG-TERM DEBT - Revolving Credit Facility (Details) - Revolving Credit Facility - USD ($)
$ in Millions
Feb. 23, 2022
Mar. 30, 2024
Debt Instrument [Line Items]    
Commitment fee rate range, depending on leverage ratio 0.375%  
Debt issuance costs $ 0.8  
Amount outstanding   $ 0.0
Maximum borrowing capacity $ 75.0 $ 75.0
Minimum    
Debt Instrument [Line Items]    
Commitment fee rate range, depending on leverage ratio 0.25%  
Maximum    
Debt Instrument [Line Items]    
Commitment fee rate range, depending on leverage ratio 0.50%  
SOFR    
Debt Instrument [Line Items]    
Basis spread on variable rate 3.50%  
Canadian Prime Rate    
Debt Instrument [Line Items]    
Basis spread on variable rate 2.50%  
EURIBOR or AUD Rate    
Debt Instrument [Line Items]    
Basis spread on variable rate 3.50%  
v3.24.1.u1
LONG-TERM DEBT - Term Loan (Details) - USD ($)
3 Months Ended
Feb. 23, 2022
Mar. 30, 2024
Apr. 01, 2023
Dec. 31, 2023
Debt Instrument [Line Items]        
Repayment of long term debt   $ 18,813,000 $ 813,000  
Amount outstanding, net of discount and issuance costs   282,781,000   $ 301,201,000
Discount and debt issuance costs   7,719,000   $ 8,112,000
Term Loan Facility        
Debt Instrument [Line Items]        
Repayment amount to be paid quarterly $ 812,500      
Principal payments calculated as percent of outstanding principal 0.25%      
Mandatory prepayment rate as a percentage of excess cash flow 50.00%      
Mandatory prepayment rate as a percentage of non-permitted indebtedness 100.00%      
Repayment of long term debt   18,000,000.0    
Amount outstanding, net of discount and issuance costs   282,800,000    
Debt issuance costs   4,300,000    
Unamortized discount   $ 3,400,000    
Effective interest rate   9.89%    
Term Loan Facility | SOFR | Minimum        
Debt Instrument [Line Items]        
Basis spread on variable rate 3.75%      
Term Loan Facility | SOFR | Maximum        
Debt Instrument [Line Items]        
Basis spread on variable rate 4.00%      
Term Loan Facility | Base Rate | Minimum        
Debt Instrument [Line Items]        
Basis spread on variable rate 2.75%      
Term Loan Facility | Base Rate | Maximum        
Debt Instrument [Line Items]        
Basis spread on variable rate 3.00%      
v3.24.1.u1
LONG-TERM DEBT - Interest rate swap (Details) - Interest rate swap - USD ($)
$ in Millions
Mar. 10, 2023
Feb. 28, 2022
Derivative [Line Items]    
Derivative notional amount $ 161.0 $ 200.0
SOFR    
Derivative [Line Items]    
Fixed borrowing rate 4.3725% 0.496%
v3.24.1.u1
LONG-TERM DEBT - Principal payments due (Details)
$ in Thousands
Mar. 30, 2024
USD ($)
Principal payments due  
Remainder of fiscal year 2024 $ 2,438
2025 3,250
2026 3,250
2027 3,250
2028 3,250
Thereafter 275,062
Total payments due $ 290,500
v3.24.1.u1
PRODUCT WARRANTIES (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Movement in Standard Product Warranty Accrual [Roll Forward]    
Balance at the beginning of the fiscal year $ 3,161 $ 3,990
Adjustments to reserve 537 354
Less: Settlements made (in cash or in kind) (679) (761)
Balance at the end of the fiscal quarter $ 3,019 $ 3,583
v3.24.1.u1
LEASES - Lease expense (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Components of lease expense:    
Operating lease expense $ 2,163 $ 2,351
Finance lease amortization of assets 212 109
Finance lease interest on lease liabilities 84 52
Short-term lease expense 56 54
Variable lease expense 158 327
Total lease expense $ 2,673 $ 2,893
v3.24.1.u1
LEASES - Operating and finance lease right-of-use assets and liabilities and Supplemental information (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Dec. 31, 2023
Lease right-of-use assets:      
Operating leases $ 28,696   $ 30,788
Finance leases $ 3,887   $ 3,912
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Other Assets   Other Assets
Total lease right-of-use assets $ 32,583   $ 34,700
Lease-related liabilities      
Operating leases, Current 6,823   7,133
Finance leases, Current $ 782   $ 746
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Current   Other Liabilities, Current
Operating leases, Non-current $ 22,963   $ 24,787
Finance leases, Non-current $ 3,247   $ 3,285
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration] Other Liabilities, Noncurrent   Other Liabilities, Noncurrent
Total finance lease liabilities $ 33,815   $ 35,951
Weighted-average remaining lease term (years)      
Finance leases 5 years   5 years 2 months 12 days
Operating leases 5 years 7 months 6 days   5 years 8 months 12 days
Weighted-average discount rate      
Finance leases 8.20%   8.20%
Operating leases 5.00%   5.10%
Cash paid for amounts included in the measurement of lease liabilities:      
Operating cash flows from operating leases $ 1,794 $ 1,817  
v3.24.1.u1
LEASES - Maturities of operating lease liabilities (Details) - USD ($)
$ in Thousands
Mar. 30, 2024
Dec. 31, 2023
Operating Leases    
Remainder of fiscal 2024 $ 6,260  
2025 7,309  
2026 5,805  
2027 4,097  
2028 3,111  
Thereafter 7,637  
Total lease payments 34,219  
Less: Interest (4,433)  
Present value of lease liability 29,786  
Finance Leases    
Remainder of fiscal 2024 813  
2025 1,030  
2026 934  
2027 858  
2028 845  
Thereafter 436  
Total lease payments 4,916  
Less: Interest (886)  
Present value of lease liability 4,030  
Total    
Remainder of fiscal year 2024 7,073  
2025 8,339  
2026 6,739  
2027 4,955  
2028 3,956  
Thereafter 8,073  
Total lease payments 39,135  
Less: Interest (5,319)  
Present value of lease liability 33,815 $ 35,951
Rounding (member)    
Total    
Present value of lease liability $ 33,816  
v3.24.1.u1
NET SALES (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Disaggregation of Revenue [Line Items]    
Net sales $ 110,629 $ 137,719
In-ground Swimming Pools    
Disaggregation of Revenue [Line Items]    
Net sales 59,832 78,612
Covers    
Disaggregation of Revenue [Line Items]    
Net sales 26,868 32,745
Liners    
Disaggregation of Revenue [Line Items]    
Net sales $ 23,929 $ 26,362
v3.24.1.u1
INCOME TAXES (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
INCOME TAXES    
Effective income tax rate (7.20%) 16.90%
Tax benefits $ 0 $ 0
v3.24.1.u1
STOCKHOLDERS' EQUITY (Details) - Repurchase Program - USD ($)
$ in Millions
3 Months Ended
Mar. 30, 2024
May 10, 2022
Amount authorized   $ 100.0
Amount remaining for repurchases $ 77.0  
Common Stock    
Number of shares repurchased during the period 0  
v3.24.1.u1
STOCK-BASED COMPENSATION - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Apr. 12, 2021
Mar. 30, 2024
Apr. 01, 2023
May 02, 2023
STOCK-BASED COMPENSATION        
Maximum grant date fair value of cash and equity awards that may be awarded to a non-employee director $ 750,000      
Shares reserved for issuance   21,170,212   8,000,000
Share based compensation expense   $ 1,243 $ 6,769  
Total unrecognized stock-based compensation expense   $ 13,300    
Total unrecognized stock-based compensation expense expected to be recognized over a weighted-average period   2 years 2 months 12 days    
Cost of sales        
STOCK-BASED COMPENSATION        
Share based compensation expense     426  
Selling, general and administrative        
STOCK-BASED COMPENSATION        
Share based compensation expense   $ 1,243 $ 6,343  
v3.24.1.u1
STOCK-BASED COMPENSATION - Restricted Stock Awards (Details) - Restricted stock awards
3 Months Ended
Mar. 30, 2024
$ / shares
shares
Shares  
Balance at beginning | shares 42,886
Granted | shares
Balance at ending | shares 42,886
Weighted Average Grant Date Fair Value  
Balance at beginning | $ / shares $ 19.00
Granted | $ / shares
Balance at ending | $ / shares $ 19.00
v3.24.1.u1
STOCK-BASED COMPENSATION - Restricted Stock Units (Details) - Restricted stock units
3 Months Ended
Mar. 30, 2024
$ / shares
shares
Shares  
Balance at beginning | shares 2,235,479
Granted | shares 2,282,336
Vested | shares (411,301)
Forfeited | shares (85,392)
Balance at ending | shares 4,021,122
Weighted Average Grant Date Fair Value  
Balance at beginning | $ / shares $ 3.60
Granted | $ / shares 2.87
Vested | $ / shares 3.94
Forfeited | $ / shares 2.93
Balance at ending | $ / shares $ 3.17
v3.24.1.u1
STOCK-BASED COMPENSATION - Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 12 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Dec. 31, 2023
Employee Stock Option      
Shares      
Outstanding at the beginning 1,554,294    
Forfeited (42,004)    
Expired (57,616)    
Outstanding at the end 1,454,674   1,554,294
Vested and expected to vest 1,454,674    
Options exercisable at the end 678,477    
Weighted-Average Exercise Price per Share      
Outstanding at the beginning (in dollars per share) $ 15.43    
Forfeited (in dollars per share) 16.92    
Expired (in dollars per share) 17.78    
Outstanding at the end (in dollars per share) 15.30   $ 15.43
Vested and expected to vest at the end (in dollars per share) 15.30    
Options exercisable at the end (in dollars per share) $ 16.10    
Weighted-Average Remaining Contract Term      
Outstanding at the end (in years) 7 years 6 months 29 days   0 years
Vested and expected to vest at the end (in years) 7 years 6 months 29 days    
Options exercisable at the end (in years) 7 years 4 months 17 days    
Stock Appreciation Rights (SARs)      
Shares      
Outstanding at the beginning 755,802    
Granted 0 790,181  
Forfeited (49,342)    
Outstanding at the end 706,460   755,802
Vested and expected to vest 706,460    
Options exercisable at the end 161,893    
Weighted-Average Exercise Price per Share      
Outstanding at the beginning (in dollars per share) $ 3.16    
Granted (in dollars per share) 3.24    
Forfeited (in dollars per share) 3.24    
Outstanding at the end (in dollars per share) 3.15   $ 3.16
Vested and expected to vest at the end (in dollars per share) 3.15    
Options exercisable at the end (in dollars per share) $ 3.24    
Weighted-Average Remaining Contract Term      
Outstanding at the end (in years) 9 years 1 month 17 days    
Vested and expected to vest at the end (in years) 9 years 1 month 17 days    
Options exercisable at the end (in years) 9 years 1 month 2 days    
Outstanding at the end (in dollars) $ 569,296    
Vested and expected to vest (in dollars) 569,296    
Options exercisable at the end (in dollars) $ 116,563    
v3.24.1.u1
STOCK-BASED COMPENSATION - Performance Stock Units (Details) - $ / shares
3 Months Ended
Mar. 30, 2024
May 02, 2023
Weighted Average Grant Date Fair Value    
Shares reserved for issuance 21,170,212 8,000,000
Performance Stock Units    
Shares    
Granted 427,145  
Balance at ending 427,145  
Weighted Average Grant Date Fair Value    
Granted $ 2.87  
Balance at ending $ 2.87  
Shares reserved for issuance 427,145  
Performance level percent 100.00%  
Performance period 1 year  
Additional shares authorized 427,145  
Performance Stock Units | Maximum    
Weighted Average Grant Date Fair Value    
Performance level percent 200.00%  
Performance Stock Units | Minimum    
Weighted Average Grant Date Fair Value    
Performance level percent 0.00%  
Performance Stock Units | Maximum performance level    
Weighted Average Grant Date Fair Value    
Performance level percent 200.00%  
v3.24.1.u1
NET LOSS PER SHARE (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Dec. 31, 2023
Numerator:      
Net loss $ (7,864) $ (14,368)  
Weighted-average common shares outstanding      
Basic 115,038,929 112,102,198  
Diluted 115,038,929 112,102,198  
Net loss per share attributable to common stockholders:      
Basic $ (0.07) $ (0.13)  
Diluted $ (0.07) $ (0.13)  
Common stock issued and outstanding for accounting purposes 115,346,803   114,828,896
Restricted stock awards      
Net loss per share attributable to common stockholders:      
Potentially dilutive securities outstanding 42,886 2,576,219  
Restricted stock units      
Net loss per share attributable to common stockholders:      
Potentially dilutive securities outstanding 24,146 500,751  
Employee Stock Option      
Net loss per share attributable to common stockholders:      
Potentially dilutive securities outstanding 1,521,158 1,886,497  
Stock appreciation rights      
Net loss per share attributable to common stockholders:      
Potentially dilutive securities outstanding 657,999    
Performance stock units      
Net loss per share attributable to common stockholders:      
Potentially dilutive securities outstanding 75,937    
v3.24.1.u1
RELATED PARTY TRANSACTIONS - Bright AI Services (Details)
$ in Millions
Dec. 31, 2023
USD ($)
Bright AI Services  
Related Party Transaction [Line Items]  
Accounts payable $ 0
v3.24.1.u1
RESTRUCTURING COSTS (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 30, 2024
Dec. 31, 2023
RESTRUCTURING COSTS    
Exit or disposal cost $ 0.1 $ 0.2
v3.24.1.u1
Pay vs Performance Disclosure - USD ($)
$ in Thousands
3 Months Ended
Mar. 30, 2024
Apr. 01, 2023
Pay vs Performance Disclosure    
Net Income (Loss) $ (7,864) $ (14,368)
v3.24.1.u1
Insider Trading Arrangements
3 Months Ended
Mar. 30, 2024
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false

Grafico Azioni Latham (NASDAQ:SWIM)
Storico
Da Nov 2024 a Dic 2024 Clicca qui per i Grafici di Latham
Grafico Azioni Latham (NASDAQ:SWIM)
Storico
Da Dic 2023 a Dic 2024 Clicca qui per i Grafici di Latham